Global Radiation Therapy Market By Offering (Products/Equipment (Imaging Systems, Linear Accelerator, Radio Therapy Simulators, Radioactive Seeds, Applicators & Afterloaders, Others), Services (Implementation and Installation, Training and Education, Support Services, Others)); By Therapy Type (External Beam Radiation Therapy (3-D Conformal Radiation Therapy (3D CRT), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy, Volumetric Modulated Arc Therapy (VMAT), Others), Internal Beam Radiation Therapy (Brachytherapy Treatment (Low-dose rate (LDR) Brachytherapy, High-dose rate (HDR) Brachytherapy), Systemic Radiation Therapy, Radioimmunotherapy (RIT), Others)); By Application (Breast Cancer, Eye Cancer, Prostate Cancer, Cervix Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, Penile Cancer, Intracranial Cancer, Pancreatic Cancer, Vaginal Cancer, Others); By End User (Hospitals, Clinics, Specialty Cancer Centers, Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Industry Trends
The increasing adoption of digitalization in radiation therapy equipment has led to creation of treatment techniques which preserve healthy tissue and reduce toxicity in patients, thus driving the growth of radiation therapy market.
The growing urban population has fostered sedentary lifestyle leading to high prevalence of diseases. Medical professionals are continuously striving to develop innovative treatment techniques for enhancing patient outcomes. Radiation therapy is a fast emerging treatment modality which uses high-energy particles from either an external machine or a radioactive substance inserted inside patient’s body to kill the harmful cells. This therapy is used in treatment of various diseases such as cancer, thyroid disease, blood disorders, noncancerous growths such as acoustic neuroma, arteriovenous malformation and many others. However, the high energy beams are prone to damaging healthy cells along with harmful ones, which creates demand for advanced solutions for improving quality of treatment. Major market players have incorporated digital systems in their offerings for better visualization and treatment. For instance, the digital linear accelerators of Elekta AB uses a wide range of delivery techniques for controlling the dosage rate and ensures maximum patient safety. Similarly, the ONCOR digital linear accelerator of Siemens rotates around the patient for monitoring the tumor and delivers radiation dosage only when the tumor is in right place, which ensures effective dosage without additional risk of side effects. These advanced digital solutions are transforming the traditional care systems and thus, driving the growth of global radiation therapy market.
Safe and effective radiation therapy requires trained staff, dedicated equipment and a highly coordinated operational department. This high complexity associated with equipment handling is hindering the growth of global radiation therapy market. However, in order to overcome the challenges associated with skilled staff for radiation therapy, many governmental organizations and hospitals are initiating training programs for radiologists. For instance, the Atomic Energy Regulatory Board Radiological Safety Division of India, National Cancer Institute of the U.S., Tata Memorial Centre and many others are providing radiotherapy technologists courses and funds for training of medical professionals. These programs are anticipated to overcome the challenges of unskilled labour and complexity in handling in global radiation therapy market.
Researchers are exploring use of 4D imaging, artificial intelligence and many other such technologies to increase the efficiency of radiation therapy treatment. Medical professional have been using conventional simulators or computerized tomography (CT) for screening of patients to gather information of body surface contours, tissue thickness and tissue deficiencies. However these methods are prone to error and are time consuming. To eliminate the errors of traditional simulators, researchers are studying the use of 4D imaging system for accurate estimation of tissue motion pattern and range for radiation therapy of moving targets. For instance, physicists from the Institute of Cancer Research, U.K and the Royal Marsden National Health Service Foundation Trust published a research study in May 2018, which demonstrates use of a 4D Magnetic resonance imaging (MRI) to accurately locate tumors and deliver more precise radiotherapy for patients. Artificial intelligence is another technology witnessing high popularity for optimizing radiation therapy planning. For instance, Varian Medical Systems, Inc. received a clearance from the U.S Food and Drug Administration in February 2020 for its Ethos therapy, which uses artificial intelligence along with CT imaging to create adaptive treatment plan in 15-minutes duration. Thus, the ongoing incorporation of advanced visualization and processing technologies are anticipated to propel the growth of global radiation therapy market in future years.
The recent outbreak of COVID-19 pandemic has infected more than 33 million people across the globe. This pandemic has created high demand for effective treatment method which has fuelled number of research activities across the globe. Researchers from Memorial Sloan Kettering Cancer Center of U.S, University of Alberta of Canada and others are exploring use of radiation therapy in treatment of COVID-19 patients. The patients infected with coronavirus often show cytokine storm, which can be treated through ultra-low-dose radiation therapy. This research activities aimed at treating COVID-19 patients with radiotherapy are expected to fuel the growth of global radiation therapy market.
End User Outlook:
Large hospitals such as University College London Hospitals, Mayo Foundation for Medical Education and Research (MFMER) and others dominated the global radiation therapy market in 2018 owing to their capacity to bear scale-up costs including the capital expenses of developing new facilities including building, equipment and training new staff as well as operating costs associated with salaries and equipment. However, these hospitals are generally located in major cities which deprives most of rural populations from radiation therapy. To tackle this challenge, multiple speciality cancer care centers are being opened to reduce the patient-traffic at hospitals and cater higher number of people. Australian Department of Health announced grants of US$ 32.09 million for opening speciality cancer care centers in various regions of the nation. Thus, the growing emergence of specialty cancer centers is anticipated to propel their share in global radiation therapy market in forecast years.
Regional Outlook:
North America region registered the highest share in global radiation therapy market in 2018, however, Asia Pacific region is anticipated to witness highest growth rate over forecast years. The access to radiation therapy in low and middle income countries of this region is severely limited. Global Taskforce on Radiotherapy for Cancer Control (GTFRCC) stated in February 2017 that more than 90% of cancer patients in low and middle income countries lack access to treatment. Similarly, Tata Memorial Hospital’s study published in 2017 stated that there were only 580 radiation therapy centers available in India. On recognizing such issues, several government as well as non-government programs are being initiated to bridge the gaps of access to radiation therapy treatments. For instance, the Parliament of Australia announced a program worth of US$ 44.92 million in 2019 budget to boost radiation therapy services. The global community including World Health Organization also offers resources to establish radiation therapy services. These initiatives are anticipated to propel the share of Asia Pacific region in global radiation therapy market over forecast period.
In terms of revenue, global radiation therapy market was valued at US$ 5506.01 Mn in 2018 and is anticipated to reach US$ 9551.47 Mn, growing at a CAGR of 6.4% over the forecast period. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Radiation Therapy Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of radiation therapy market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the radiation therapy market are Accuray Incorporated, Elekta AB, Hitachi, Ltd, IBA Worldwide, IntraOp Medical, Inc., Mevion Medical Systems., Nordion (Canada) Inc., Panacea Medical Technologies Pvt. Ltd, Provision Healthcare, Radiology Oncology Systems, Sensus Healthcare, Varian Medical Systems, Inc., VIEWRAY TECHNOLOGIES, INC. and ZEISS Medical Technology amongst others.
These market players are strategizing to expand their presence across multiple regions and expand their product offerings through merger and acquisition (M&A) activities. For instance, Elekta AB, a Swedish radiation therapy equipment manufacturer, acquired ProKnow, a digital technology company, in August 2019 to strengthen their market position with novel offerings. Similarly, Varian Medical Systems, Inc. acquired Cancer Treatment Services International, Inc. in May 2019 to gain patient and clinical data insights for enhancing existing portfolio and developing new products and services.
Global Radiation Therapy Market:
By Offering
- Products/Equipment
- Imaging Systems
- Linear Accelerator
- Radio Therapy Simulators
- Radioactive Seeds
- Applicators & Afterloaders
- Others
- Services
- Implementation and Installation
- Training and Education
- Support Services
- Others
By Therapy Type
- External Beam Radiation Therapy
- 3-D Conformal Radiation Therapy (3D CRT)
- Intensity-Modulated Radiation Therapy (IMRT)
- Image-Guided Radiation Therapy (IGRT)
- Stereotactic Body Radiation Therapy
- Volumetric Modulated Arc Therapy (VMAT)
- Others
- Internal Beam Radiation Therapy
- Brachytherapy Treatment
- Low-dose rate (LDR) Brachytherapy
- High-dose rate (HDR) Brachytherapy
- Systemic Radiation Therapy
- Radioimmunotherapy (RIT)
- Others
- Brachytherapy Treatment
By Application
- Breast Cancer
- Eye Cancer
- Prostate Cancer
- Cervix Cancer
- Lung Cancer
- Head and Neck Cancer
- Colorectal Cancer
- Penile Cancer
- Intracranial Cancer
- Pancreatic Cancer
- Vaginal Cancer
- Others
By End User
- Hospitals
- Clinics
- Specialty Cancer Centers
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2013 - 2017
1.2.2. Base Year: 2018
1.2.3. Forecast Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Radiation Therapy
Market
6. Market Synopsis: Radiation Therapy Market
7. Radiation Therapy Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Radiation Therapy Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Radiation Therapy Market
7.6. Porter’s Five Force Analysis
7.7. Analysis on Impact of Covid-19 on Global
Radiation Therapy Market
8. Global Radiation Therapy Market Analysis and
Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global Radiation Therapy Market Revenue (US$
Mn)
8.2. Global Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
8.2.1. Products/Equipment (Definition, Market
Estimation and Penetration, 2013 – 2018, Market Estimation (2013 – 2018),
Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Imaging Systems, Linear Accelerator, Radio Therapy
Simulators, Radioactive Seeds, Applicators and Afterloaders, Others)
8.2.1.1. Imaging Systems
8.2.1.2. Linear Accelerator
8.2.1.3. Radio Therapy Simulators
8.2.1.4. Radioactive Seeds
8.2.1.5. Applicators and Afterloaders
8.2.1.6. Others
8.2.2. Services (Definition, Market Estimation and
Penetration, 2013 – 2018, Market Estimation (2013 – 2018), Market Forecast
(2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Implementation and Installation, Training and Education, Support
Services, Others)
8.2.2.1. Implementation and Installation
8.2.2.2. Training and Education
8.2.2.3. Support Services
8.2.2.4. Others
8.3. Key Segment for Channeling Investments
8.3.1. By Offering
9. Global Radiation Therapy Market Analysis and
Forecasts, 2019 – 2027
9.1. Overview
9.2. Global Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
9.2.1. External Beam Radiation Therapy (Definition,
Market Estimation and Penetration, 2013 – 2018, Market Estimation (2013 –
2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR),
Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and
Africa, Latin America) and Information on 3-D Conformal Radiation Therapy (3D
CRT), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation
Therapy (IGRT), Stereotactic Body Radiation Therapy, Volumetric Modulated Arc
Therapy (VMAT), Others)
9.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
9.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
9.2.1.3. Image-Guided Radiation Therapy (IGRT)
9.2.1.4. Stereotactic Body Radiation Therapy
9.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
9.2.1.6. Others
9.2.2. Internal Beam Radiation Therapy (Definition,
Market Estimation and Penetration, 2013 – 2018, Market Estimation (2013 –
2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR),
Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and
Africa, Latin America) and Information on Brachytherapy Treatment, Systemic
Radiation Therapy, Radioimmunotherapy (RIT), Others)
9.2.2.1. Brachytherapy Treatment
9.2.2.1.1. Low-dose rate (LDR) Brachytherapy
9.2.2.1.2. High-dose rate (HDR) Brachytherapy
9.2.2.2. Systemic Radiation Therapy
9.2.2.3. Radioimmunotherapy (RIT)
9.2.2.4. Others
9.3. Key Segment for Channeling Investments
9.3.1. By Therapy Type
10. Global Radiation Therapy Market Analysis and
Forecasts, 2019 – 2027
10.1. Overview
10.2. Global Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
10.2.1. Breast Cancer
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2013 –
2018
10.2.1.3. Market Forecast, 2019 – 2027
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market Estimation, 2013 – 2018
10.2.1.5.1.2. Market Forecast, 2019 – 2027
10.2.1.5.2. Europe
10.2.1.5.2.1. Market Estimation, 2013 – 2018
10.2.1.5.2.2. Market Forecast, 2019 – 2027
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market Estimation, 2013 – 2018
10.2.1.5.3.2. Market Forecast, 2019 – 2027
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market Estimation, 2013 – 2018
10.2.1.5.4.2. Market Forecast, 2019 – 2027
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market Estimation, 2013 – 2018
10.2.1.5.5.2. Market Forecast, 2019 – 2027
10.2.2. Eye Cancer
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2013 –
2018
10.2.2.3. Market Forecast, 2019 – 2027
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2013 – 2018
10.2.2.5.1.2. Market Forecast, 2019 – 2027
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2013 – 2018
10.2.2.5.2.2. Market Forecast, 2019 – 2027
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2013 – 2018
10.2.2.5.3.2. Market Forecast, 2019 – 2027
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2013 – 2018
10.2.2.5.4.2. Market Forecast, 2019 – 2027
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2013 – 2018
10.2.2.5.5.2. Market Forecast, 2019 – 2027
10.2.3. Prostate Cancer
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2013 –
2018
10.2.3.3. Market Forecast, 2019 – 2027
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2013 – 2018
10.2.3.5.1.2. Market Forecast, 2019 – 2027
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2013 – 2018
10.2.3.5.2.2. Market Forecast, 2019 – 2027
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2013 – 2018
10.2.3.5.3.2. Market Forecast, 2019 – 2027
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2013 – 2018
10.2.3.5.4.2. Market Forecast, 2019 – 2027
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2013 – 2018
10.2.3.5.5.2. Market Forecast, 2019 – 2027
10.2.4. Cervix Cancer
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2013 –
2018
10.2.4.3. Market Forecast, 2019 – 2027
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2013 – 2018
10.2.4.5.1.2. Market Forecast, 2019 – 2027
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2013 – 2018
10.2.4.5.2.2. Market Forecast, 2019 – 2027
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2013 – 2018
10.2.4.5.3.2. Market Forecast, 2019 – 2027
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2013 – 2018
10.2.4.5.4.2. Market Forecast, 2019 – 2027
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2013 – 2018
10.2.4.5.5.2. Market Forecast, 2019 – 2027
10.2.5. Lung Cancer
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2013 –
2018
10.2.5.3. Market Forecast, 2019 – 2027
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market Estimation, 2013 – 2018
10.2.5.5.1.2. Market Forecast, 2019 – 2027
10.2.5.5.2. Europe
10.2.5.5.2.1. Market Estimation, 2013 – 2018
10.2.5.5.2.2. Market Forecast, 2019 – 2027
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market Estimation, 2013 – 2018
10.2.5.5.3.2. Market Forecast, 2019 – 2027
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market Estimation, 2013 – 2018
10.2.5.5.4.2. Market Forecast, 2019 – 2027
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market Estimation, 2013 – 2018
10.2.5.5.5.2. Market Forecast, 2019 – 2027
10.2.6. Head and Neck Cancer
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2013 –
2018
10.2.6.3. Market Forecast, 2019 – 2027
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market Estimation, 2013 – 2018
10.2.6.5.1.2. Market Forecast, 2019 – 2027
10.2.6.5.2. Europe
10.2.6.5.2.1. Market Estimation, 2013 – 2018
10.2.6.5.2.2. Market Forecast, 2019 – 2027
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market Estimation, 2013 – 2018
10.2.6.5.3.2. Market Forecast, 2019 – 2027
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market Estimation, 2013 – 2018
10.2.6.5.4.2. Market Forecast, 2019 – 2027
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market Estimation, 2013 – 2018
10.2.6.5.5.2. Market Forecast, 2019 – 2027
10.2.7. Colorectal Cancer
10.2.7.1. Definition
10.2.7.2. Market Estimation and Penetration, 2013 –
2018
10.2.7.3. Market Forecast, 2019 – 2027
10.2.7.4. Compound Annual Growth Rate (CAGR)
10.2.7.5. Regional Bifurcation
10.2.7.5.1. North America
10.2.7.5.1.1. Market Estimation, 2013 – 2018
10.2.7.5.1.2. Market Forecast, 2019 – 2027
10.2.7.5.2. Europe
10.2.7.5.2.1. Market Estimation, 2013 – 2018
10.2.7.5.2.2. Market Forecast, 2019 – 2027
10.2.7.5.3. Asia Pacific
10.2.7.5.3.1. Market Estimation, 2013 – 2018
10.2.7.5.3.2. Market Forecast, 2019 – 2027
10.2.7.5.4. Middle East and Africa
10.2.7.5.4.1. Market Estimation, 2013 – 2018
10.2.7.5.4.2. Market Forecast, 2019 – 2027
10.2.7.5.5. Latin America
10.2.7.5.5.1. Market Estimation, 2013 – 2018
10.2.7.5.5.2. Market Forecast, 2019 – 2027
10.2.8. Penile Cancer
10.2.8.1. Definition
10.2.8.2. Market Estimation and Penetration, 2013 –
2018
10.2.8.3. Market Forecast, 2019 – 2027
10.2.8.4. Compound Annual Growth Rate (CAGR)
10.2.8.5. Regional Bifurcation
10.2.8.5.1. North America
10.2.8.5.1.1. Market Estimation, 2013 – 2018
10.2.8.5.1.2. Market Forecast, 2019 – 2027
10.2.8.5.2. Europe
10.2.8.5.2.1. Market Estimation, 2013 – 2018
10.2.8.5.2.2. Market Forecast, 2019 – 2027
10.2.8.5.3. Asia Pacific
10.2.8.5.3.1. Market Estimation, 2013 – 2018
10.2.8.5.3.2. Market Forecast, 2019 – 2027
10.2.8.5.4. Middle East and Africa
10.2.8.5.4.1. Market Estimation, 2013 – 2018
10.2.8.5.4.2. Market Forecast, 2019 – 2027
10.2.8.5.5. Latin America
10.2.8.5.5.1. Market Estimation, 2013 – 2018
10.2.8.5.5.2. Market Forecast, 2019 – 2027
10.2.9. Intracranial Cancer
10.2.9.1. Definition
10.2.9.2. Market Estimation and Penetration, 2013 –
2018
10.2.9.3. Market Forecast, 2019 – 2027
10.2.9.4. Compound Annual Growth Rate (CAGR)
10.2.9.5. Regional Bifurcation
10.2.9.5.1. North America
10.2.9.5.1.1. Market Estimation, 2013 – 2018
10.2.9.5.1.2. Market Forecast, 2019 – 2027
10.2.9.5.2. Europe
10.2.9.5.2.1. Market Estimation, 2013 – 2018
10.2.9.5.2.2. Market Forecast, 2019 – 2027
10.2.9.5.3. Asia Pacific
10.2.9.5.3.1. Market Estimation, 2013 – 2018
10.2.9.5.3.2. Market Forecast, 2019 – 2027
10.2.9.5.4. Middle East and Africa
10.2.9.5.4.1. Market Estimation, 2013 – 2018
10.2.9.5.4.2. Market Forecast, 2019 – 2027
10.2.9.5.5. Latin America
10.2.9.5.5.1. Market Estimation, 2013 – 2018
10.2.9.5.5.2. Market Forecast, 2019 – 2027
10.2.10. Pancreatic Cancer
10.2.10.1. Definition
10.2.10.2. Market Estimation and Penetration, 2013 –
2018
10.2.10.3. Market Forecast, 2019 – 2027
10.2.10.4. Compound Annual Growth Rate (CAGR)
10.2.10.5. Regional Bifurcation
10.2.10.5.1. North America
10.2.10.5.1.1. Market Estimation, 2013 – 2018
10.2.10.5.1.2. Market Forecast, 2019 – 2027
10.2.10.5.2. Europe
10.2.10.5.2.1. Market Estimation, 2013 – 2018
10.2.10.5.2.2. Market Forecast, 2019 – 2027
10.2.10.5.3. Asia Pacific
10.2.10.5.3.1. Market Estimation, 2013 – 2018
10.2.10.5.3.2. Market Forecast, 2019 – 2027
10.2.10.5.4. Middle East and Africa
10.2.10.5.4.1. Market Estimation, 2013 – 2018
10.2.10.5.4.2. Market Forecast, 2019 – 2027
10.2.10.5.5. Latin America
10.2.10.5.5.1. Market Estimation, 2013 – 2018
10.2.10.5.5.2. Market Forecast, 2019 – 2027
10.2.11. Vaginal Cancer
10.2.11.1. Definition
10.2.11.2. Market Estimation and Penetration, 2013 –
2018
10.2.11.3. Market Forecast, 2019 – 2027
10.2.11.4. Compound Annual Growth Rate (CAGR)
10.2.11.5. Regional Bifurcation
10.2.11.5.1. North America
10.2.11.5.1.1. Market Estimation, 2013 – 2018
10.2.11.5.1.2. Market Forecast, 2019 – 2027
10.2.11.5.2. Europe
10.2.11.5.2.1. Market Estimation, 2013 – 2018
10.2.11.5.2.2. Market Forecast, 2019 – 2027
10.2.11.5.3. Asia Pacific
10.2.11.5.3.1. Market Estimation, 2013 – 2018
10.2.11.5.3.2. Market Forecast, 2019 – 2027
10.2.11.5.4. Middle East and Africa
10.2.11.5.4.1. Market Estimation, 2013 – 2018
10.2.11.5.4.2. Market Forecast, 2019 – 2027
10.2.11.5.5. Latin America
10.2.11.5.5.1. Market Estimation, 2013 – 2018
10.2.11.5.5.2. Market Forecast, 2019 – 2027
10.2.12. Others
10.2.12.1. Definition
10.2.12.2. Market Estimation and Penetration, 2013 –
2018
10.2.12.3. Market Forecast, 2019 – 2027
10.2.12.4. Compound Annual Growth Rate (CAGR)
10.2.12.5. Regional Bifurcation
10.2.12.5.1. North America
10.2.12.5.1.1. Market Estimation, 2013 – 2018
10.2.12.5.1.2. Market Forecast, 2019 – 2027
10.2.12.5.2. Europe
10.2.12.5.2.1. Market Estimation, 2013 – 2018
10.2.12.5.2.2. Market Forecast, 2019 – 2027
10.2.12.5.3. Asia Pacific
10.2.12.5.3.1. Market Estimation, 2013 – 2018
10.2.12.5.3.2. Market Forecast, 2019 – 2027
10.2.12.5.4. Middle East and Africa
10.2.12.5.4.1. Market Estimation, 2013 – 2018
10.2.12.5.4.2. Market Forecast, 2019 – 2027
10.2.12.5.5. Latin America
10.2.12.5.5.1. Market Estimation, 2013 – 2018
10.2.12.5.5.2. Market Forecast, 2019 – 2027
10.3. Key Segment for Channeling Investments
10.3.1. By Application
11. Global Radiation Therapy Market Analysis and
Forecasts, 2019 – 2027
11.1. Overview
11.2. Global Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
11.2.1. Hospitals
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2013 –
2018
11.2.1.3. Market Forecast, 2019 – 2027
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market Estimation, 2013 – 2018
11.2.1.5.1.2. Market Forecast, 2019 – 2027
11.2.1.5.2. Europe
11.2.1.5.2.1. Market Estimation, 2013 – 2018
11.2.1.5.2.2. Market Forecast, 2019 – 2027
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market Estimation, 2013 – 2018
11.2.1.5.3.2. Market Forecast, 2019 – 2027
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market Estimation, 2013 – 2018
11.2.1.5.4.2. Market Forecast, 2019 – 2027
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market Estimation, 2013 – 2018
11.2.1.5.5.2. Market Forecast, 2019 – 2027
11.2.2. Clinics
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2013 –
2018
11.2.2.3. Market Forecast, 2019 – 2027
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market Estimation, 2013 – 2018
11.2.2.5.1.2. Market Forecast, 2019 – 2027
11.2.2.5.2. Europe
11.2.2.5.2.1. Market Estimation, 2013 – 2018
11.2.2.5.2.2. Market Forecast, 2019 – 2027
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market Estimation, 2013 – 2018
11.2.2.5.3.2. Market Forecast, 2019 – 2027
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market Estimation, 2013 – 2018
11.2.2.5.4.2. Market Forecast, 2019 – 2027
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market Estimation, 2013 – 2018
11.2.2.5.5.2. Market Forecast, 2019 – 2027
11.2.3. Specialty Cancer Centers
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2013 –
2018
11.2.3.3. Market Forecast, 2019 – 2027
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market Estimation, 2013 – 2018
11.2.3.5.1.2. Market Forecast, 2019 – 2027
11.2.3.5.2. Europe
11.2.3.5.2.1. Market Estimation, 2013 – 2018
11.2.3.5.2.2. Market Forecast, 2019 – 2027
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market Estimation, 2013 – 2018
11.2.3.5.3.2. Market Forecast, 2019 – 2027
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market Estimation, 2013 – 2018
11.2.3.5.4.2. Market Forecast, 2019 – 2027
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market Estimation, 2013 – 2018
11.2.3.5.5.2. Market Forecast, 2019 – 2027
11.2.4. Others
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2013 –
2018
11.2.4.3. Market Forecast, 2019 – 2027
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market Estimation, 2013 – 2018
11.2.4.5.1.2. Market Forecast, 2019 – 2027
11.2.4.5.2. Europe
11.2.4.5.2.1. Market Estimation, 2013 – 2018
11.2.4.5.2.2. Market Forecast, 2019 – 2027
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market Estimation, 2013 – 2018
11.2.4.5.3.2. Market Forecast, 2019 – 2027
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market Estimation, 2013 – 2018
11.2.4.5.4.2. Market Forecast, 2019 – 2027
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market Estimation, 2013 – 2018
11.2.4.5.5.2. Market Forecast, 2019 – 2027
11.3. Key Segment for Channeling Investments
11.3.1. By End User
12. North America Radiation Therapy Market
Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. North America Radiation Therapy Market
Revenue (US$ Mn)
12.2. North America Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Offering
12.2.1. Products/Equipment
12.2.1.1. Imaging Systems
12.2.1.2. Linear Accelerator
12.2.1.3. Radio Therapy Simulators
12.2.1.4. Radioactive Seeds
12.2.1.5. Applicators and Afterloaders
12.2.1.6. Others
12.2.2. Services
12.2.2.1. Implementation and Installation
12.2.2.2. Training and Education
12.2.2.3. Support Services
12.2.2.4. Others
12.3. North America Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
12.3.1. External Beam Radiation Therapy
12.3.1.1. 3-D Conformal Radiation Therapy (3D CRT)
12.3.1.2. Intensity-Modulated Radiation Therapy (IMRT)
12.3.1.3. Image-Guided Radiation Therapy (IGRT)
12.3.1.4. Stereotactic Body Radiation Therapy
12.3.1.5. Volumetric Modulated Arc Therapy (VMAT)
12.3.1.6. Others
12.3.2. Internal Beam Radiation Therapy
12.3.2.1. Brachytherapy Treatment
12.3.2.1.1. Low-dose rate (LDR) Brachytherapy
12.3.2.1.2. High-dose rate (HDR) Brachytherapy
12.3.2.2. Systemic Radiation Therapy
12.3.2.3. Radioimmunotherapy (RIT)
12.3.2.4. Others
12.4. North America Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Application
12.4.1. Breast Cancer
12.4.2. Eye Cancer
12.4.3. Prostate Cancer
12.4.4. Cervix Cancer
12.4.5. Lung Cancer
12.4.6. Head and Neck Cancer
12.4.7. Colorectal Cancer
12.4.8. Penile Cancer
12.4.9. Intracranial Cancer
12.4.10. Pancreatic Cancer
12.4.11. Vaginal Cancer
12.4.12. Others
12.5. North America Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By End User
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Specialty Cancer Centers
12.5.4. Others
12.6. North America Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Radiation Therapy Market Revenue (US$ Mn)
and Forecasts, By Offering
12.6.1.1.1. Products/Equipment
12.6.1.1.1.1. Imaging Systems
12.6.1.1.1.2. Linear Accelerator
12.6.1.1.1.3. Radio Therapy Simulators
12.6.1.1.1.4. Radioactive Seeds
12.6.1.1.1.5. Applicators and Afterloaders
12.6.1.1.1.6. Others
12.6.1.1.2. Services
12.6.1.1.2.1. Implementation and Installation
12.6.1.1.2.2. Training and Education
12.6.1.1.2.3. Support Services
12.6.1.1.2.4. Others
12.6.1.2. U.S Radiation Therapy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
12.6.1.2.1. External Beam Radiation Therapy
12.6.1.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
12.6.1.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
12.6.1.2.1.3. Image-Guided Radiation Therapy (IGRT)
12.6.1.2.1.4. Stereotactic Body Radiation Therapy
12.6.1.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
12.6.1.2.1.6. Others
12.6.1.2.2. Internal Beam Radiation Therapy
12.6.1.2.2.1. Brachytherapy Treatment
12.6.1.2.2.1.1. Low-dose rate (LDR) Brachytherapy
12.6.1.2.2.1.2. High-dose rate (HDR) Brachytherapy
12.6.1.2.2.2. Systemic Radiation Therapy
12.6.1.2.2.3. Radioimmunotherapy (RIT)
12.6.1.2.2.4. Others
12.6.1.3. U.S Radiation Therapy Market Revenue (US$ Mn)
and Forecasts, By Application
12.6.1.3.1. Breast Cancer
12.6.1.3.2. Eye Cancer
12.6.1.3.3. Prostate Cancer
12.6.1.3.4. Cervix Cancer
12.6.1.3.5. Lung Cancer
12.6.1.3.6. Head and Neck Cancer
12.6.1.3.7. Colorectal Cancer
12.6.1.3.8. Penile Cancer
12.6.1.3.9. Intracranial Cancer
12.6.1.3.10. Pancreatic Cancer
12.6.1.3.11. Vaginal Cancer
12.6.1.3.12. Others
12.6.1.4. U.S Radiation Therapy Market Revenue (US$ Mn)
and Forecasts, By End User
12.6.1.4.1. Hospitals
12.6.1.4.2. Clinics
12.6.1.4.3. Specialty Cancer Centers
12.6.1.4.4. Others
12.6.2. Canada
12.6.2.1. Canada Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
12.6.2.1.1. Products/Equipment
12.6.2.1.1.1. Imaging Systems
12.6.2.1.1.2. Linear Accelerator
12.6.2.1.1.3. Radio Therapy Simulators
12.6.2.1.1.4. Radioactive Seeds
12.6.2.1.1.5. Applicators and Afterloaders
12.6.2.1.1.6. Others
12.6.2.1.2. Services
12.6.2.1.2.1. Implementation and Installation
12.6.2.1.2.2. Training and Education
12.6.2.1.2.3. Support Services
12.6.2.1.2.4. Others
12.6.2.2. Canada Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
12.6.2.2.1. External Beam Radiation Therapy
12.6.2.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
12.6.2.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
12.6.2.2.1.3. Image-Guided Radiation Therapy (IGRT)
12.6.2.2.1.4. Stereotactic Body Radiation Therapy
12.6.2.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
12.6.2.2.1.6. Others
12.6.2.2.2. Internal Beam Radiation Therapy
12.6.2.2.2.1. Brachytherapy Treatment
12.6.2.2.2.1.1. Low-dose rate (LDR) Brachytherapy
12.6.2.2.2.1.2. High-dose rate (HDR) Brachytherapy
12.6.2.2.2.2. Systemic Radiation Therapy
12.6.2.2.2.3. Radioimmunotherapy (RIT)
12.6.2.2.2.4. Others
12.6.2.3. Canada Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
12.6.2.3.1. Breast Cancer
12.6.2.3.2. Eye Cancer
12.6.2.3.3. Prostate Cancer
12.6.2.3.4. Cervix Cancer
12.6.2.3.5. Lung Cancer
12.6.2.3.6. Head and Neck Cancer
12.6.2.3.7. Colorectal Cancer
12.6.2.3.8. Penile Cancer
12.6.2.3.9. Intracranial Cancer
12.6.2.3.10. Pancreatic Cancer
12.6.2.3.11. Vaginal Cancer
12.6.2.3.12. Others
12.6.2.4. Canada Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
12.6.2.4.1. Hospitals
12.6.2.4.2. Clinics
12.6.2.4.3. Specialty Cancer Centers
12.6.2.4.4. Others
12.6.3. Mexico
12.6.3.1. Mexico Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
12.6.3.1.1. Products/Equipment
12.6.3.1.1.1. Imaging Systems
12.6.3.1.1.2. Linear Accelerator
12.6.3.1.1.3. Radio Therapy Simulators
12.6.3.1.1.4. Radioactive Seeds
12.6.3.1.1.5. Applicators and Afterloaders
12.6.3.1.1.6. Others
12.6.3.1.2. Services
12.6.3.1.2.1. Implementation and Installation
12.6.3.1.2.2. Training and Education
12.6.3.1.2.3. Support Services
12.6.3.1.2.4. Others
12.6.3.2. Mexico Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
12.6.3.2.1. External Beam Radiation Therapy
12.6.3.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
12.6.3.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
12.6.3.2.1.3. Image-Guided Radiation Therapy (IGRT)
12.6.3.2.1.4. Stereotactic Body Radiation Therapy
12.6.3.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
12.6.3.2.1.6. Others
12.6.3.2.2. Internal Beam Radiation Therapy
12.6.3.2.2.1. Brachytherapy Treatment
12.6.3.2.2.1.1. Low-dose rate (LDR) Brachytherapy
12.6.3.2.2.1.2. High-dose rate (HDR) Brachytherapy
12.6.3.2.2.2. Systemic Radiation Therapy
12.6.3.2.2.3. Radioimmunotherapy (RIT)
12.6.3.2.2.4. Others
12.6.3.3. Mexico Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
12.6.3.3.1. Breast Cancer
12.6.3.3.2. Eye Cancer
12.6.3.3.3. Prostate Cancer
12.6.3.3.4. Cervix Cancer
12.6.3.3.5. Lung Cancer
12.6.3.3.6. Head and Neck Cancer
12.6.3.3.7. Colorectal Cancer
12.6.3.3.8. Penile Cancer
12.6.3.3.9. Intracranial Cancer
12.6.3.3.10. Pancreatic Cancer
12.6.3.3.11. Vaginal Cancer
12.6.3.3.12. Others
12.6.3.4. Mexico Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
12.6.3.4.1. Hospitals
12.6.3.4.2. Clinics
12.6.3.4.3. Specialty Cancer Centers
12.6.3.4.4. Others
12.6.4. Rest of North America
12.6.4.1. Rest of North America Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By Offering
12.6.4.1.1. Products/Equipment
12.6.4.1.1.1. Imaging Systems
12.6.4.1.1.2. Linear Accelerator
12.6.4.1.1.3. Radio Therapy Simulators
12.6.4.1.1.4. Radioactive Seeds
12.6.4.1.1.5. Applicators and Afterloaders
12.6.4.1.1.6. Others
12.6.4.1.2. Services
12.6.4.1.2.1. Implementation and Installation
12.6.4.1.2.2. Training and Education
12.6.4.1.2.3. Support Services
12.6.4.1.2.4. Others
12.6.4.2. Rest of North America Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
12.6.4.2.1. External Beam Radiation Therapy
12.6.4.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
12.6.4.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
12.6.4.2.1.3. Image-Guided Radiation Therapy (IGRT)
12.6.4.2.1.4. Stereotactic Body Radiation Therapy
12.6.4.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
12.6.4.2.1.6. Others
12.6.4.2.2. Internal Beam Radiation Therapy
12.6.4.2.2.1. Brachytherapy Treatment
12.6.4.2.2.1.1. Low-dose rate (LDR) Brachytherapy
12.6.4.2.2.1.2. High-dose rate (HDR) Brachytherapy
12.6.4.2.2.2. Systemic Radiation Therapy
12.6.4.2.2.3. Radioimmunotherapy (RIT)
12.6.4.2.2.4. Others
12.6.4.3. Rest of North America Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By Application
12.6.4.3.1. Breast Cancer
12.6.4.3.2. Eye Cancer
12.6.4.3.3. Prostate Cancer
12.6.4.3.4. Cervix Cancer
12.6.4.3.5. Lung Cancer
12.6.4.3.6. Head and Neck Cancer
12.6.4.3.7. Colorectal Cancer
12.6.4.3.8. Penile Cancer
12.6.4.3.9. Intracranial Cancer
12.6.4.3.10. Pancreatic Cancer
12.6.4.3.11. Vaginal Cancer
12.6.4.3.12. Others
12.6.4.4. Rest of North America Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By End User
12.6.4.4.1. Hospitals
12.6.4.4.2. Clinics
12.6.4.4.3. Specialty Cancer Centers
12.6.4.4.4. Others
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Offering
12.7.3. By Therapy Type
12.7.4. By Application
12.7.5. By End User
13. Europe Radiation Therapy Market Analysis and
Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Europe Radiation Therapy Market Revenue (US$
Mn)
13.2. Europe Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
13.2.1. Products/Equipment
13.2.1.1. Imaging Systems
13.2.1.2. Linear Accelerator
13.2.1.3. Radio Therapy Simulators
13.2.1.4. Radioactive Seeds
13.2.1.5. Applicators and Afterloaders
13.2.1.6. Others
13.2.2. Services
13.2.2.1. Implementation and Installation
13.2.2.2. Training and Education
13.2.2.3. Support Services
13.2.2.4. Others
13.3. Europe Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
13.3.1. External Beam Radiation Therapy
13.3.1.1. 3-D Conformal Radiation Therapy (3D CRT)
13.3.1.2. Intensity-Modulated Radiation Therapy (IMRT)
13.3.1.3. Image-Guided Radiation Therapy (IGRT)
13.3.1.4. Stereotactic Body Radiation Therapy
13.3.1.5. Volumetric Modulated Arc Therapy (VMAT)
13.3.1.6. Others
13.3.2. Internal Beam Radiation Therapy
13.3.2.1. Brachytherapy Treatment
13.3.2.1.1. Low-dose rate (LDR) Brachytherapy
13.3.2.1.2. High-dose rate (HDR) Brachytherapy
13.3.2.2. Systemic Radiation Therapy
13.3.2.3. Radioimmunotherapy (RIT)
13.3.2.4. Others
13.4. Europe Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
13.4.1. Breast Cancer
13.4.2. Eye Cancer
13.4.3. Prostate Cancer
13.4.4. Cervix Cancer
13.4.5. Lung Cancer
13.4.6. Head and Neck Cancer
13.4.7. Colorectal Cancer
13.4.8. Penile Cancer
13.4.9. Intracranial Cancer
13.4.10. Pancreatic Cancer
13.4.11. Vaginal Cancer
13.4.12. Others
13.5. Europe Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Specialty Cancer Centers
13.5.4. Others
13.6. Europe Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.1.1.1. Products/Equipment
13.6.1.1.1.1. Imaging Systems
13.6.1.1.1.2. Linear Accelerator
13.6.1.1.1.3. Radio Therapy Simulators
13.6.1.1.1.4. Radioactive Seeds
13.6.1.1.1.5. Applicators and Afterloaders
13.6.1.1.1.6. Others
13.6.1.1.2. Services
13.6.1.1.2.1. Implementation and Installation
13.6.1.1.2.2. Training and Education
13.6.1.1.2.3. Support Services
13.6.1.1.2.4. Others
13.6.1.2. France Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
13.6.1.2.1. External Beam Radiation Therapy
13.6.1.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
13.6.1.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
13.6.1.2.1.3. Image-Guided Radiation Therapy (IGRT)
13.6.1.2.1.4. Stereotactic Body Radiation Therapy
13.6.1.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
13.6.1.2.1.6. Others
13.6.1.2.2. Internal Beam Radiation Therapy
13.6.1.2.2.1. Brachytherapy Treatment
13.6.1.2.2.1.1. Low-dose rate (LDR) Brachytherapy
13.6.1.2.2.1.2. High-dose rate (HDR) Brachytherapy
13.6.1.2.2.2. Systemic Radiation Therapy
13.6.1.2.2.3. Radioimmunotherapy (RIT)
13.6.1.2.2.4. Others
13.6.1.3. France Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
13.6.1.3.1. Breast Cancer
13.6.1.3.2. Eye Cancer
13.6.1.3.3. Prostate Cancer
13.6.1.3.4. Cervix Cancer
13.6.1.3.5. Lung Cancer
13.6.1.3.6. Head and Neck Cancer
13.6.1.3.7. Colorectal Cancer
13.6.1.3.8. Penile Cancer
13.6.1.3.9. Intracranial Cancer
13.6.1.3.10. Pancreatic Cancer
13.6.1.3.11. Vaginal Cancer
13.6.1.3.12. Others
13.6.1.4. France Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
13.6.1.4.1. Hospitals
13.6.1.4.2. Clinics
13.6.1.4.3. Specialty Cancer Centers
13.6.1.4.4. Others
13.6.2. The UK
13.6.2.1. The UK Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.2.1.1. Products/Equipment
13.6.2.1.1.1. Imaging Systems
13.6.2.1.1.2. Linear Accelerator
13.6.2.1.1.3. Radio Therapy Simulators
13.6.2.1.1.4. Radioactive Seeds
13.6.2.1.1.5. Applicators and Afterloaders
13.6.2.1.1.6. Others
13.6.2.1.2. Services
13.6.2.1.2.1. Implementation and Installation
13.6.2.1.2.2. Training and Education
13.6.2.1.2.3. Support Services
13.6.2.1.2.4. Others
13.6.2.2. The UK Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
13.6.2.2.1. External Beam Radiation Therapy
13.6.2.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
13.6.2.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
13.6.2.2.1.3. Image-Guided Radiation Therapy (IGRT)
13.6.2.2.1.4. Stereotactic Body Radiation Therapy
13.6.2.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
13.6.2.2.1.6. Others
13.6.2.2.2. Internal Beam Radiation Therapy
13.6.2.2.2.1. Brachytherapy Treatment
13.6.2.2.2.1.1. Low-dose rate (LDR) Brachytherapy
13.6.2.2.2.1.2. High-dose rate (HDR) Brachytherapy
13.6.2.2.2.2. Systemic Radiation Therapy
13.6.2.2.2.3. Radioimmunotherapy (RIT)
13.6.2.2.2.4. Others
13.6.2.3. The UK Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
13.6.2.3.1. Breast Cancer
13.6.2.3.2. Eye Cancer
13.6.2.3.3. Prostate Cancer
13.6.2.3.4. Cervix Cancer
13.6.2.3.5. Lung Cancer
13.6.2.3.6. Head and Neck Cancer
13.6.2.3.7. Colorectal Cancer
13.6.2.3.8. Penile Cancer
13.6.2.3.9. Intracranial Cancer
13.6.2.3.10. Pancreatic Cancer
13.6.2.3.11. Vaginal Cancer
13.6.2.3.12. Others
13.6.2.4. The UK Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
13.6.2.4.1. Hospitals
13.6.2.4.2. Clinics
13.6.2.4.3. Specialty Cancer Centers
13.6.2.4.4. Others
13.6.3. Spain
13.6.3.1. Spain Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.3.1.1. Products/Equipment
13.6.3.1.1.1. Imaging Systems
13.6.3.1.1.2. Linear Accelerator
13.6.3.1.1.3. Radio Therapy Simulators
13.6.3.1.1.4. Radioactive Seeds
13.6.3.1.1.5. Applicators and Afterloaders
13.6.3.1.1.6. Others
13.6.3.1.2. Services
13.6.3.1.2.1. Implementation and Installation
13.6.3.1.2.2. Training and Education
13.6.3.1.2.3. Support Services
13.6.3.1.2.4. Others
13.6.3.2. Spain Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
13.6.3.2.1. External Beam Radiation Therapy
13.6.3.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
13.6.3.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
13.6.3.2.1.3. Image-Guided Radiation Therapy (IGRT)
13.6.3.2.1.4. Stereotactic Body Radiation Therapy
13.6.3.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
13.6.3.2.1.6. Others
13.6.3.2.2. Internal Beam Radiation Therapy
13.6.3.2.2.1. Brachytherapy Treatment
13.6.3.2.2.1.1. Low-dose rate (LDR) Brachytherapy
13.6.3.2.2.1.2. High-dose rate (HDR) Brachytherapy
13.6.3.2.2.2. Systemic Radiation Therapy
13.6.3.2.2.3. Radioimmunotherapy (RIT)
13.6.3.2.2.4. Others
13.6.3.3. Spain Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
13.6.3.3.1. Breast Cancer
13.6.3.3.2. Eye Cancer
13.6.3.3.3. Prostate Cancer
13.6.3.3.4. Cervix Cancer
13.6.3.3.5. Lung Cancer
13.6.3.3.6. Head and Neck Cancer
13.6.3.3.7. Colorectal Cancer
13.6.3.3.8. Penile Cancer
13.6.3.3.9. Intracranial Cancer
13.6.3.3.10. Pancreatic Cancer
13.6.3.3.11. Vaginal Cancer
13.6.3.3.12. Others
13.6.3.4. Spain Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
13.6.3.4.1. Hospitals
13.6.3.4.2. Clinics
13.6.3.4.3. Specialty Cancer Centers
13.6.3.4.4. Others
13.6.4. Germany
13.6.4.1. Germany Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.4.1.1. Products/Equipment
13.6.4.1.1.1. Imaging Systems
13.6.4.1.1.2. Linear Accelerator
13.6.4.1.1.3. Radio Therapy Simulators
13.6.4.1.1.4. Radioactive Seeds
13.6.4.1.1.5. Applicators and Afterloaders
13.6.4.1.1.6. Others
13.6.4.1.2. Services
13.6.4.1.2.1. Implementation and Installation
13.6.4.1.2.2. Training and Education
13.6.4.1.2.3. Support Services
13.6.4.1.2.4. Others
13.6.4.2. Germany Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
13.6.4.2.1. External Beam Radiation Therapy
13.6.4.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
13.6.4.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
13.6.4.2.1.3. Image-Guided Radiation Therapy (IGRT)
13.6.4.2.1.4. Stereotactic Body Radiation Therapy
13.6.4.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
13.6.4.2.1.6. Others
13.6.4.2.2. Internal Beam Radiation Therapy
13.6.4.2.2.1. Brachytherapy Treatment
13.6.4.2.2.1.1. Low-dose rate (LDR) Brachytherapy
13.6.4.2.2.1.2. High-dose rate (HDR) Brachytherapy
13.6.4.2.2.2. Systemic Radiation Therapy
13.6.4.2.2.3. Radioimmunotherapy (RIT)
13.6.4.2.2.4. Others
13.6.4.3. Germany Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
13.6.4.3.1. Breast Cancer
13.6.4.3.2. Eye Cancer
13.6.4.3.3. Prostate Cancer
13.6.4.3.4. Cervix Cancer
13.6.4.3.5. Lung Cancer
13.6.4.3.6. Head and Neck Cancer
13.6.4.3.7. Colorectal Cancer
13.6.4.3.8. Penile Cancer
13.6.4.3.9. Intracranial Cancer
13.6.4.3.10. Pancreatic Cancer
13.6.4.3.11. Vaginal Cancer
13.6.4.3.12. Others
13.6.4.4. Germany Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
13.6.4.4.1. Hospitals
13.6.4.4.2. Clinics
13.6.4.4.3. Specialty Cancer Centers
13.6.4.4.4. Others
13.6.5. Italy
13.6.5.1. Italy Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.5.1.1. Products/Equipment
13.6.5.1.1.1. Imaging Systems
13.6.5.1.1.2. Linear Accelerator
13.6.5.1.1.3. Radio Therapy Simulators
13.6.5.1.1.4. Radioactive Seeds
13.6.5.1.1.5. Applicators and Afterloaders
13.6.5.1.1.6. Others
13.6.5.1.2. Services
13.6.5.1.2.1. Implementation and Installation
13.6.5.1.2.2. Training and Education
13.6.5.1.2.3. Support Services
13.6.5.1.2.4. Others
13.6.5.2. Italy Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
13.6.5.2.1. External Beam Radiation Therapy
13.6.5.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
13.6.5.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
13.6.5.2.1.3. Image-Guided Radiation Therapy (IGRT)
13.6.5.2.1.4. Stereotactic Body Radiation Therapy
13.6.5.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
13.6.5.2.1.6. Others
13.6.5.2.2. Internal Beam Radiation Therapy
13.6.5.2.2.1. Brachytherapy Treatment
13.6.5.2.2.1.1. Low-dose rate (LDR) Brachytherapy
13.6.5.2.2.1.2. High-dose rate (HDR) Brachytherapy
13.6.5.2.2.2. Systemic Radiation Therapy
13.6.5.2.2.3. Radioimmunotherapy (RIT)
13.6.5.2.2.4. Others
13.6.5.3. Italy Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
13.6.5.3.1. Breast Cancer
13.6.5.3.2. Eye Cancer
13.6.5.3.3. Prostate Cancer
13.6.5.3.4. Cervix Cancer
13.6.5.3.5. Lung Cancer
13.6.5.3.6. Head and Neck Cancer
13.6.5.3.7. Colorectal Cancer
13.6.5.3.8. Penile Cancer
13.6.5.3.9. Intracranial Cancer
13.6.5.3.10. Pancreatic Cancer
13.6.5.3.11. Vaginal Cancer
13.6.5.3.12. Others
13.6.5.4. Italy Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
13.6.5.4.1. Hospitals
13.6.5.4.2. Clinics
13.6.5.4.3. Specialty Cancer Centers
13.6.5.4.4. Others
13.6.6. Nordic Countries
13.6.6.1. Nordic Countries Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Offering
13.6.6.1.1. Products/Equipment
13.6.6.1.1.1. Imaging Systems
13.6.6.1.1.2. Linear Accelerator
13.6.6.1.1.3. Radio Therapy Simulators
13.6.6.1.1.4. Radioactive Seeds
13.6.6.1.1.5. Applicators and Afterloaders
13.6.6.1.1.6. Others
13.6.6.1.2. Services
13.6.6.1.2.1. Implementation and Installation
13.6.6.1.2.2. Training and Education
13.6.6.1.2.3. Support Services
13.6.6.1.2.4. Others
13.6.6.2. Nordic Countries Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.6.2.1. External Beam Radiation Therapy
13.6.6.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
13.6.6.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
13.6.6.2.1.3. Image-Guided Radiation Therapy (IGRT)
13.6.6.2.1.4. Stereotactic Body Radiation Therapy
13.6.6.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
13.6.6.2.1.6. Others
13.6.6.2.2. Internal Beam Radiation Therapy
13.6.6.2.2.1. Brachytherapy Treatment
13.6.6.2.2.1.1. Low-dose rate (LDR) Brachytherapy
13.6.6.2.2.1.2. High-dose rate (HDR) Brachytherapy
13.6.6.2.2.2. Systemic Radiation Therapy
13.6.6.2.2.3. Radioimmunotherapy (RIT)
13.6.6.2.2.4. Others
13.6.6.3. Nordic Countries Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Application
13.6.6.3.1. Breast Cancer
13.6.6.3.2. Eye Cancer
13.6.6.3.3. Prostate Cancer
13.6.6.3.4. Cervix Cancer
13.6.6.3.5. Lung Cancer
13.6.6.3.6. Head and Neck Cancer
13.6.6.3.7. Colorectal Cancer
13.6.6.3.8. Penile Cancer
13.6.6.3.9. Intracranial Cancer
13.6.6.3.10. Pancreatic Cancer
13.6.6.3.11. Vaginal Cancer
13.6.6.3.12. Others
13.6.6.4. Nordic Countries Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By End User
13.6.6.4.1. Hospitals
13.6.6.4.2. Clinics
13.6.6.4.3. Specialty Cancer Centers
13.6.6.4.4. Others
13.6.6.5. Nordic Countries Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux Union
13.6.7.1. Benelux Union Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Offering
13.6.7.1.1. Products/Equipment
13.6.7.1.1.1. Imaging Systems
13.6.7.1.1.2. Linear Accelerator
13.6.7.1.1.3. Radio Therapy Simulators
13.6.7.1.1.4. Radioactive Seeds
13.6.7.1.1.5. Applicators and Afterloaders
13.6.7.1.1.6. Others
13.6.7.1.2. Services
13.6.7.1.2.1. Implementation and Installation
13.6.7.1.2.2. Training and Education
13.6.7.1.2.3. Support Services
13.6.7.1.2.4. Others
13.6.7.2. Benelux Union Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.7.2.1. External Beam Radiation Therapy
13.6.7.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
13.6.7.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
13.6.7.2.1.3. Image-Guided Radiation Therapy (IGRT)
13.6.7.2.1.4. Stereotactic Body Radiation Therapy
13.6.7.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
13.6.7.2.1.6. Others
13.6.7.2.2. Internal Beam Radiation Therapy
13.6.7.2.2.1. Brachytherapy Treatment
13.6.7.2.2.1.1. Low-dose rate (LDR) Brachytherapy
13.6.7.2.2.1.2. High-dose rate (HDR) Brachytherapy
13.6.7.2.2.2. Systemic Radiation Therapy
13.6.7.2.2.3. Radioimmunotherapy (RIT)
13.6.7.2.2.4. Others
13.6.7.3. Benelux Union Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Application
13.6.7.3.1. Breast Cancer
13.6.7.3.2. Eye Cancer
13.6.7.3.3. Prostate Cancer
13.6.7.3.4. Cervix Cancer
13.6.7.3.5. Lung Cancer
13.6.7.3.6. Head and Neck Cancer
13.6.7.3.7. Colorectal Cancer
13.6.7.3.8. Penile Cancer
13.6.7.3.9. Intracranial Cancer
13.6.7.3.10. Pancreatic Cancer
13.6.7.3.11. Vaginal Cancer
13.6.7.3.12. Others
13.6.7.4. Benelux Union Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By End User
13.6.7.4.1. Hospitals
13.6.7.4.2. Clinics
13.6.7.4.3. Specialty Cancer Centers
13.6.7.4.4. Others
13.6.7.5. Benelux Union Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of Europe
13.6.8.1. Rest of Europe Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Offering
13.6.8.1.1. Products/Equipment
13.6.8.1.1.1. Imaging Systems
13.6.8.1.1.2. Linear Accelerator
13.6.8.1.1.3. Radio Therapy Simulators
13.6.8.1.1.4. Radioactive Seeds
13.6.8.1.1.5. Applicators and Afterloaders
13.6.8.1.1.6. Others
13.6.8.1.2. Services
13.6.8.1.2.1. Implementation and Installation
13.6.8.1.2.2. Training and Education
13.6.8.1.2.3. Support Services
13.6.8.1.2.4. Others
13.6.8.2. Rest of Europe Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
13.6.8.2.1. External Beam Radiation Therapy
13.6.8.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
13.6.8.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
13.6.8.2.1.3. Image-Guided Radiation Therapy (IGRT)
13.6.8.2.1.4. Stereotactic Body Radiation Therapy
13.6.8.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
13.6.8.2.1.6. Others
13.6.8.2.2. Internal Beam Radiation Therapy
13.6.8.2.2.1. Brachytherapy Treatment
13.6.8.2.2.1.1. Low-dose rate (LDR) Brachytherapy
13.6.8.2.2.1.2. High-dose rate (HDR) Brachytherapy
13.6.8.2.2.2. Systemic Radiation Therapy
13.6.8.2.2.3. Radioimmunotherapy (RIT)
13.6.8.2.2.4. Others
13.6.8.3. Rest of Europe Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Application
13.6.8.3.1. Breast Cancer
13.6.8.3.2. Eye Cancer
13.6.8.3.3. Prostate Cancer
13.6.8.3.4. Cervix Cancer
13.6.8.3.5. Lung Cancer
13.6.8.3.6. Head and Neck Cancer
13.6.8.3.7. Colorectal Cancer
13.6.8.3.8. Penile Cancer
13.6.8.3.9. Intracranial Cancer
13.6.8.3.10. Pancreatic Cancer
13.6.8.3.11. Vaginal Cancer
13.6.8.3.12. Others
13.6.8.4. Rest of Europe Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By End User
13.6.8.4.1. Hospitals
13.6.8.4.2. Clinics
13.6.8.4.3. Specialty Cancer Centers
13.6.8.4.4. Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Offering
13.7.3. By Therapy Type
13.7.4. By Application
13.7.5. By End User
14. Asia Pacific Radiation Therapy Market
Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Asia Pacific Radiation Therapy Market Revenue
(US$ Mn)
14.2. Asia Pacific Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Offering
14.2.1. Products/Equipment
14.2.1.1. Imaging Systems
14.2.1.2. Linear Accelerator
14.2.1.3. Radio Therapy Simulators
14.2.1.4. Radioactive Seeds
14.2.1.5. Applicators and Afterloaders
14.2.1.6. Others
14.2.2. Services
14.2.2.1. Implementation and Installation
14.2.2.2. Training and Education
14.2.2.3. Support Services
14.2.2.4. Others
14.3. Asia Pacific Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
14.3.1. External Beam Radiation Therapy
14.3.1.1. 3-D Conformal Radiation Therapy (3D CRT)
14.3.1.2. Intensity-Modulated Radiation Therapy (IMRT)
14.3.1.3. Image-Guided Radiation Therapy (IGRT)
14.3.1.4. Stereotactic Body Radiation Therapy
14.3.1.5. Volumetric Modulated Arc Therapy (VMAT)
14.3.1.6. Others
14.3.2. Internal Beam Radiation Therapy
14.3.2.1. Brachytherapy Treatment
14.3.2.1.1. Low-dose rate (LDR) Brachytherapy
14.3.2.1.2. High-dose rate (HDR) Brachytherapy
14.3.2.2. Systemic Radiation Therapy
14.3.2.3. Radioimmunotherapy (RIT)
14.3.2.4. Others
14.4. Asia Pacific Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Application
14.4.1. Breast Cancer
14.4.2. Eye Cancer
14.4.3. Prostate Cancer
14.4.4. Cervix Cancer
14.4.5. Lung Cancer
14.4.6. Head and Neck Cancer
14.4.7. Colorectal Cancer
14.4.8. Penile Cancer
14.4.9. Intracranial Cancer
14.4.10. Pancreatic Cancer
14.4.11. Vaginal Cancer
14.4.12. Others
14.5. Asia Pacific Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By End User
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Specialty Cancer Centers
14.5.4. Others
14.6. Asia Pacific Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.1.1.1. Products/Equipment
14.6.1.1.1.1. Imaging Systems
14.6.1.1.1.2. Linear Accelerator
14.6.1.1.1.3. Radio Therapy Simulators
14.6.1.1.1.4. Radioactive Seeds
14.6.1.1.1.5. Applicators and Afterloaders
14.6.1.1.1.6. Others
14.6.1.1.2. Services
14.6.1.1.2.1. Implementation and Installation
14.6.1.1.2.2. Training and Education
14.6.1.1.2.3. Support Services
14.6.1.1.2.4. Others
14.6.1.2. China Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
14.6.1.2.1. External Beam Radiation Therapy
14.6.1.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
14.6.1.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
14.6.1.2.1.3. Image-Guided Radiation Therapy (IGRT)
14.6.1.2.1.4. Stereotactic Body Radiation Therapy
14.6.1.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
14.6.1.2.1.6. Others
14.6.1.2.2. Internal Beam Radiation Therapy
14.6.1.2.2.1. Brachytherapy Treatment
14.6.1.2.2.1.1. Low-dose rate (LDR) Brachytherapy
14.6.1.2.2.1.2. High-dose rate (HDR) Brachytherapy
14.6.1.2.2.2. Systemic Radiation Therapy
14.6.1.2.2.3. Radioimmunotherapy (RIT)
14.6.1.2.2.4. Others
14.6.1.3. China Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
14.6.1.3.1. Breast Cancer
14.6.1.3.2. Eye Cancer
14.6.1.3.3. Prostate Cancer
14.6.1.3.4. Cervix Cancer
14.6.1.3.5. Lung Cancer
14.6.1.3.6. Head and Neck Cancer
14.6.1.3.7. Colorectal Cancer
14.6.1.3.8. Penile Cancer
14.6.1.3.9. Intracranial Cancer
14.6.1.3.10. Pancreatic Cancer
14.6.1.3.11. Vaginal Cancer
14.6.1.3.12. Others
14.6.1.4. China Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
14.6.1.4.1. Hospitals
14.6.1.4.2. Clinics
14.6.1.4.3. Specialty Cancer Centers
14.6.1.4.4. Others
14.6.2. Japan
14.6.2.1. Japan Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.2.1.1. Products/Equipment
14.6.2.1.1.1. Imaging Systems
14.6.2.1.1.2. Linear Accelerator
14.6.2.1.1.3. Radio Therapy Simulators
14.6.2.1.1.4. Radioactive Seeds
14.6.2.1.1.5. Applicators and Afterloaders
14.6.2.1.1.6. Others
14.6.2.1.2. Services
14.6.2.1.2.1. Implementation and Installation
14.6.2.1.2.2. Training and Education
14.6.2.1.2.3. Support Services
14.6.2.1.2.4. Others
14.6.2.2. Japan Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
14.6.2.2.1. External Beam Radiation Therapy
14.6.2.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
14.6.2.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
14.6.2.2.1.3. Image-Guided Radiation Therapy (IGRT)
14.6.2.2.1.4. Stereotactic Body Radiation Therapy
14.6.2.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
14.6.2.2.1.6. Others
14.6.2.2.2. Internal Beam Radiation Therapy
14.6.2.2.2.1. Brachytherapy Treatment
14.6.2.2.2.1.1. Low-dose rate (LDR) Brachytherapy
14.6.2.2.2.1.2. High-dose rate (HDR) Brachytherapy
14.6.2.2.2.2. Systemic Radiation Therapy
14.6.2.2.2.3. Radioimmunotherapy (RIT)
14.6.2.2.2.4. Others
14.6.2.3. Japan Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
14.6.2.3.1. Breast Cancer
14.6.2.3.2. Eye Cancer
14.6.2.3.3. Prostate Cancer
14.6.2.3.4. Cervix Cancer
14.6.2.3.5. Lung Cancer
14.6.2.3.6. Head and Neck Cancer
14.6.2.3.7. Colorectal Cancer
14.6.2.3.8. Penile Cancer
14.6.2.3.9. Intracranial Cancer
14.6.2.3.10. Pancreatic Cancer
14.6.2.3.11. Vaginal Cancer
14.6.2.3.12. Others
14.6.2.4. Japan Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
14.6.2.4.1. Hospitals
14.6.2.4.2. Clinics
14.6.2.4.3. Specialty Cancer Centers
14.6.2.4.4. Others
14.6.3. India
14.6.3.1. India Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.3.1.1. Products/Equipment
14.6.3.1.1.1. Imaging Systems
14.6.3.1.1.2. Linear Accelerator
14.6.3.1.1.3. Radio Therapy Simulators
14.6.3.1.1.4. Radioactive Seeds
14.6.3.1.1.5. Applicators and Afterloaders
14.6.3.1.1.6. Others
14.6.3.1.2. Services
14.6.3.1.2.1. Implementation and Installation
14.6.3.1.2.2. Training and Education
14.6.3.1.2.3. Support Services
14.6.3.1.2.4. Others
14.6.3.2. India Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
14.6.3.2.1. External Beam Radiation Therapy
14.6.3.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
14.6.3.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
14.6.3.2.1.3. Image-Guided Radiation Therapy (IGRT)
14.6.3.2.1.4. Stereotactic Body Radiation Therapy
14.6.3.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
14.6.3.2.1.6. Others
14.6.3.2.2. Internal Beam Radiation Therapy
14.6.3.2.2.1. Brachytherapy Treatment
14.6.3.2.2.1.1. Low-dose rate (LDR) Brachytherapy
14.6.3.2.2.1.2. High-dose rate (HDR) Brachytherapy
14.6.3.2.2.2. Systemic Radiation Therapy
14.6.3.2.2.3. Radioimmunotherapy (RIT)
14.6.3.2.2.4. Others
14.6.3.3. India Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
14.6.3.3.1. Breast Cancer
14.6.3.3.2. Eye Cancer
14.6.3.3.3. Prostate Cancer
14.6.3.3.4. Cervix Cancer
14.6.3.3.5. Lung Cancer
14.6.3.3.6. Head and Neck Cancer
14.6.3.3.7. Colorectal Cancer
14.6.3.3.8. Penile Cancer
14.6.3.3.9. Intracranial Cancer
14.6.3.3.10. Pancreatic Cancer
14.6.3.3.11. Vaginal Cancer
14.6.3.3.12. Others
14.6.3.4. India Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
14.6.3.4.1. Hospitals
14.6.3.4.2. Clinics
14.6.3.4.3. Specialty Cancer Centers
14.6.3.4.4. Others
14.6.4. New Zealand
14.6.4.1. New Zealand Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Offering
14.6.4.1.1. Products/Equipment
14.6.4.1.1.1. Imaging Systems
14.6.4.1.1.2. Linear Accelerator
14.6.4.1.1.3. Radio Therapy Simulators
14.6.4.1.1.4. Radioactive Seeds
14.6.4.1.1.5. Applicators and Afterloaders
14.6.4.1.1.6. Others
14.6.4.1.2. Services
14.6.4.1.2.1. Implementation and Installation
14.6.4.1.2.2. Training and Education
14.6.4.1.2.3. Support Services
14.6.4.1.2.4. Others
14.6.4.2. New Zealand Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
14.6.4.2.1. External Beam Radiation Therapy
14.6.4.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
14.6.4.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
14.6.4.2.1.3. Image-Guided Radiation Therapy (IGRT)
14.6.4.2.1.4. Stereotactic Body Radiation Therapy
14.6.4.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
14.6.4.2.1.6. Others
14.6.4.2.2. Internal Beam Radiation Therapy
14.6.4.2.2.1. Brachytherapy Treatment
14.6.4.2.2.1.1. Low-dose rate (LDR) Brachytherapy
14.6.4.2.2.1.2. High-dose rate (HDR) Brachytherapy
14.6.4.2.2.2. Systemic Radiation Therapy
14.6.4.2.2.3. Radioimmunotherapy (RIT)
14.6.4.2.2.4. Others
14.6.4.3. New Zealand Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.4.3.1. Breast Cancer
14.6.4.3.2. Eye Cancer
14.6.4.3.3. Prostate Cancer
14.6.4.3.4. Cervix Cancer
14.6.4.3.5. Lung Cancer
14.6.4.3.6. Head and Neck Cancer
14.6.4.3.7. Colorectal Cancer
14.6.4.3.8. Penile Cancer
14.6.4.3.9. Intracranial Cancer
14.6.4.3.10. Pancreatic Cancer
14.6.4.3.11. Vaginal Cancer
14.6.4.3.12. Others
14.6.4.4. New Zealand Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By End User
14.6.4.4.1. Hospitals
14.6.4.4.2. Clinics
14.6.4.4.3. Specialty Cancer Centers
14.6.4.4.4. Others
14.6.5. Australia
14.6.5.1. Australia Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Offering
14.6.5.1.1. Products/Equipment
14.6.5.1.1.1. Imaging Systems
14.6.5.1.1.2. Linear Accelerator
14.6.5.1.1.3. Radio Therapy Simulators
14.6.5.1.1.4. Radioactive Seeds
14.6.5.1.1.5. Applicators and Afterloaders
14.6.5.1.1.6. Others
14.6.5.1.2. Services
14.6.5.1.2.1. Implementation and Installation
14.6.5.1.2.2. Training and Education
14.6.5.1.2.3. Support Services
14.6.5.1.2.4. Others
14.6.5.2. Australia Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
14.6.5.2.1. External Beam Radiation Therapy
14.6.5.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
14.6.5.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
14.6.5.2.1.3. Image-Guided Radiation Therapy (IGRT)
14.6.5.2.1.4. Stereotactic Body Radiation Therapy
14.6.5.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
14.6.5.2.1.6. Others
14.6.5.2.2. Internal Beam Radiation Therapy
14.6.5.2.2.1. Brachytherapy Treatment
14.6.5.2.2.1.1. Low-dose rate (LDR) Brachytherapy
14.6.5.2.2.1.2. High-dose rate (HDR) Brachytherapy
14.6.5.2.2.2. Systemic Radiation Therapy
14.6.5.2.2.3. Radioimmunotherapy (RIT)
14.6.5.2.2.4. Others
14.6.5.3. Australia Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.5.3.1. Breast Cancer
14.6.5.3.2. Eye Cancer
14.6.5.3.3. Prostate Cancer
14.6.5.3.4. Cervix Cancer
14.6.5.3.5. Lung Cancer
14.6.5.3.6. Head and Neck Cancer
14.6.5.3.7. Colorectal Cancer
14.6.5.3.8. Penile Cancer
14.6.5.3.9. Intracranial Cancer
14.6.5.3.10. Pancreatic Cancer
14.6.5.3.11. Vaginal Cancer
14.6.5.3.12. Others
14.6.5.4. Australia Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By End User
14.6.5.4.1. Hospitals
14.6.5.4.2. Clinics
14.6.5.4.3. Specialty Cancer Centers
14.6.5.4.4. Others
14.6.6. South Korea
14.6.6.1. South Korea Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Offering
14.6.6.1.1. Products/Equipment
14.6.6.1.1.1. Imaging Systems
14.6.6.1.1.2. Linear Accelerator
14.6.6.1.1.3. Radio Therapy Simulators
14.6.6.1.1.4. Radioactive Seeds
14.6.6.1.1.5. Applicators and Afterloaders
14.6.6.1.1.6. Others
14.6.6.1.2. Services
14.6.6.1.2.1. Implementation and Installation
14.6.6.1.2.2. Training and Education
14.6.6.1.2.3. Support Services
14.6.6.1.2.4. Others
14.6.6.2. South Korea Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
14.6.6.2.1. External Beam Radiation Therapy
14.6.6.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
14.6.6.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
14.6.6.2.1.3. Image-Guided Radiation Therapy (IGRT)
14.6.6.2.1.4. Stereotactic Body Radiation Therapy
14.6.6.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
14.6.6.2.1.6. Others
14.6.6.2.2. Internal Beam Radiation Therapy
14.6.6.2.2.1. Brachytherapy Treatment
14.6.6.2.2.1.1. Low-dose rate (LDR) Brachytherapy
14.6.6.2.2.1.2. High-dose rate (HDR) Brachytherapy
14.6.6.2.2.2. Systemic Radiation Therapy
14.6.6.2.2.3. Radioimmunotherapy (RIT)
14.6.6.2.2.4. Others
14.6.6.3. South Korea Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.6.3.1. Breast Cancer
14.6.6.3.2. Eye Cancer
14.6.6.3.3. Prostate Cancer
14.6.6.3.4. Cervix Cancer
14.6.6.3.5. Lung Cancer
14.6.6.3.6. Head and Neck Cancer
14.6.6.3.7. Colorectal Cancer
14.6.6.3.8. Penile Cancer
14.6.6.3.9. Intracranial Cancer
14.6.6.3.10. Pancreatic Cancer
14.6.6.3.11. Vaginal Cancer
14.6.6.3.12. Others
14.6.6.4. South Korea Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By End User
14.6.6.4.1. Hospitals
14.6.6.4.2. Clinics
14.6.6.4.3. Specialty Cancer Centers
14.6.6.4.4. Others
14.6.7. Southeast Asia
14.6.7.1. Southeast Asia Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Offering
14.6.7.1.1. Products/Equipment
14.6.7.1.1.1. Imaging Systems
14.6.7.1.1.2. Linear Accelerator
14.6.7.1.1.3. Radio Therapy Simulators
14.6.7.1.1.4. Radioactive Seeds
14.6.7.1.1.5. Applicators and Afterloaders
14.6.7.1.1.6. Others
14.6.7.1.2. Services
14.6.7.1.2.1. Implementation and Installation
14.6.7.1.2.2. Training and Education
14.6.7.1.2.3. Support Services
14.6.7.1.2.4. Others
14.6.7.2. Southeast Asia Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
14.6.7.2.1. External Beam Radiation Therapy
14.6.7.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
14.6.7.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
14.6.7.2.1.3. Image-Guided Radiation Therapy (IGRT)
14.6.7.2.1.4. Stereotactic Body Radiation Therapy
14.6.7.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
14.6.7.2.1.6. Others
14.6.7.2.2. Internal Beam Radiation Therapy
14.6.7.2.2.1. Brachytherapy Treatment
14.6.7.2.2.1.1. Low-dose rate (LDR) Brachytherapy
14.6.7.2.2.1.2. High-dose rate (HDR) Brachytherapy
14.6.7.2.2.2. Systemic Radiation Therapy
14.6.7.2.2.3. Radioimmunotherapy (RIT)
14.6.7.2.2.4. Others
14.6.7.3. Southeast Asia Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Application
14.6.7.3.1. Breast Cancer
14.6.7.3.2. Eye Cancer
14.6.7.3.3. Prostate Cancer
14.6.7.3.4. Cervix Cancer
14.6.7.3.5. Lung Cancer
14.6.7.3.6. Head and Neck Cancer
14.6.7.3.7. Colorectal Cancer
14.6.7.3.8. Penile Cancer
14.6.7.3.9. Intracranial Cancer
14.6.7.3.10. Pancreatic Cancer
14.6.7.3.11. Vaginal Cancer
14.6.7.3.12. Others
14.6.7.4. Southeast Asia Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By End User
14.6.7.4.1. Hospitals
14.6.7.4.2. Clinics
14.6.7.4.3. Specialty Cancer Centers
14.6.7.4.4. Others
14.6.7.5. Southeast Asia Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1. Rest of Asia Pacific Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Offering
14.6.8.1.1. Products/Equipment
14.6.8.1.1.1. Imaging Systems
14.6.8.1.1.2. Linear Accelerator
14.6.8.1.1.3. Radio Therapy Simulators
14.6.8.1.1.4. Radioactive Seeds
14.6.8.1.1.5. Applicators and Afterloaders
14.6.8.1.1.6. Others
14.6.8.1.2. Services
14.6.8.1.2.1. Implementation and Installation
14.6.8.1.2.2. Training and Education
14.6.8.1.2.3. Support Services
14.6.8.1.2.4. Others
14.6.8.2. Rest of Asia Pacific Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
14.6.8.2.1. External Beam Radiation Therapy
14.6.8.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
14.6.8.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
14.6.8.2.1.3. Image-Guided Radiation Therapy (IGRT)
14.6.8.2.1.4. Stereotactic Body Radiation Therapy
14.6.8.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
14.6.8.2.1.6. Others
14.6.8.2.2. Internal Beam Radiation Therapy
14.6.8.2.2.1. Brachytherapy Treatment
14.6.8.2.2.1.1. Low-dose rate (LDR) Brachytherapy
14.6.8.2.2.1.2. High-dose rate (HDR) Brachytherapy
14.6.8.2.2.2. Systemic Radiation Therapy
14.6.8.2.2.3. Radioimmunotherapy (RIT)
14.6.8.2.2.4. Others
14.6.8.3. Rest of Asia Pacific Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Application
14.6.8.3.1. Breast Cancer
14.6.8.3.2. Eye Cancer
14.6.8.3.3. Prostate Cancer
14.6.8.3.4. Cervix Cancer
14.6.8.3.5. Lung Cancer
14.6.8.3.6. Head and Neck Cancer
14.6.8.3.7. Colorectal Cancer
14.6.8.3.8. Penile Cancer
14.6.8.3.9. Intracranial Cancer
14.6.8.3.10. Pancreatic Cancer
14.6.8.3.11. Vaginal Cancer
14.6.8.3.12. Others
14.6.8.4. Rest of Asia Pacific Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By End User
14.6.8.4.1. Hospitals
14.6.8.4.2. Clinics
14.6.8.4.3. Specialty Cancer Centers
14.6.8.4.4. Others
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Offering
14.7.3. By Therapy Type
14.7.4. By Application
14.7.5. By End User
15. Middle East and Africa Radiation Therapy
Market Analysis and Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Middle East and Africa Radiation Therapy
Market Revenue (US$ Mn)
15.2. Middle East and Africa Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By Offering
15.2.1. Products/Equipment
15.2.1.1. Imaging Systems
15.2.1.2. Linear Accelerator
15.2.1.3. Radio Therapy Simulators
15.2.1.4. Radioactive Seeds
15.2.1.5. Applicators and Afterloaders
15.2.1.6. Others
15.2.2. Services
15.2.2.1. Implementation and Installation
15.2.2.2. Training and Education
15.2.2.3. Support Services
15.2.2.4. Others
15.3. Middle East and Africa Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
15.3.1. External Beam Radiation Therapy
15.3.1.1. 3-D Conformal Radiation Therapy (3D CRT)
15.3.1.2. Intensity-Modulated Radiation Therapy (IMRT)
15.3.1.3. Image-Guided Radiation Therapy (IGRT)
15.3.1.4. Stereotactic Body Radiation Therapy
15.3.1.5. Volumetric Modulated Arc Therapy (VMAT)
15.3.1.6. Others
15.3.2. Internal Beam Radiation Therapy
15.3.2.1. Brachytherapy Treatment
15.3.2.1.1. Low-dose rate (LDR) Brachytherapy
15.3.2.1.2. High-dose rate (HDR) Brachytherapy
15.3.2.2. Systemic Radiation Therapy
15.3.2.3. Radioimmunotherapy (RIT)
15.3.2.4. Others
15.4. Middle East and Africa Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1. Breast Cancer
15.4.2. Eye Cancer
15.4.3. Prostate Cancer
15.4.4. Cervix Cancer
15.4.5. Lung Cancer
15.4.6. Head and Neck Cancer
15.4.7. Colorectal Cancer
15.4.8. Penile Cancer
15.4.9. Intracranial Cancer
15.4.10. Pancreatic Cancer
15.4.11. Vaginal Cancer
15.4.12. Others
15.5. Middle East and Africa Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By End User
15.5.1. Hospitals
15.5.2. Clinics
15.5.3. Specialty Cancer Centers
15.5.4. Others
15.6. Middle East and Africa Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1. Saudi Arabia Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Offering
15.6.1.1.1. Products/Equipment
15.6.1.1.1.1. Imaging Systems
15.6.1.1.1.2. Linear Accelerator
15.6.1.1.1.3. Radio Therapy Simulators
15.6.1.1.1.4. Radioactive Seeds
15.6.1.1.1.5. Applicators and Afterloaders
15.6.1.1.1.6. Others
15.6.1.1.2. Services
15.6.1.1.2.1. Implementation and Installation
15.6.1.1.2.2. Training and Education
15.6.1.1.2.3. Support Services
15.6.1.1.2.4. Others
15.6.1.2. Saudi Arabia Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
15.6.1.2.1. External Beam Radiation Therapy
15.6.1.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
15.6.1.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
15.6.1.2.1.3. Image-Guided Radiation Therapy (IGRT)
15.6.1.2.1.4. Stereotactic Body Radiation Therapy
15.6.1.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
15.6.1.2.1.6. Others
15.6.1.2.2. Internal Beam Radiation Therapy
15.6.1.2.2.1. Brachytherapy Treatment
15.6.1.2.2.1.1. Low-dose rate (LDR) Brachytherapy
15.6.1.2.2.1.2. High-dose rate (HDR) Brachytherapy
15.6.1.2.2.2. Systemic Radiation Therapy
15.6.1.2.2.3. Radioimmunotherapy (RIT)
15.6.1.2.2.4. Others
15.6.1.3. Saudi Arabia Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Application
15.6.1.3.1. Breast Cancer
15.6.1.3.2. Eye Cancer
15.6.1.3.3. Prostate Cancer
15.6.1.3.4. Cervix Cancer
15.6.1.3.5. Lung Cancer
15.6.1.3.6. Head and Neck Cancer
15.6.1.3.7. Colorectal Cancer
15.6.1.3.8. Penile Cancer
15.6.1.3.9. Intracranial Cancer
15.6.1.3.10. Pancreatic Cancer
15.6.1.3.11. Vaginal Cancer
15.6.1.3.12. Others
15.6.1.4. Saudi Arabia Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By End User
15.6.1.4.1. Hospitals
15.6.1.4.2. Clinics
15.6.1.4.3. Specialty Cancer Centers
15.6.1.4.4. Others
15.6.2. UAE
15.6.2.1. UAE Radiation Therapy Market Revenue (US$ Mn)
and Forecasts, By Offering
15.6.2.1.1. Products/Equipment
15.6.2.1.1.1. Imaging Systems
15.6.2.1.1.2. Linear Accelerator
15.6.2.1.1.3. Radio Therapy Simulators
15.6.2.1.1.4. Radioactive Seeds
15.6.2.1.1.5. Applicators and Afterloaders
15.6.2.1.1.6. Others
15.6.2.1.2. Services
15.6.2.1.2.1. Implementation and Installation
15.6.2.1.2.2. Training and Education
15.6.2.1.2.3. Support Services
15.6.2.1.2.4. Others
15.6.2.2. UAE Radiation Therapy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
15.6.2.2.1. External Beam Radiation Therapy
15.6.2.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
15.6.2.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
15.6.2.2.1.3. Image-Guided Radiation Therapy (IGRT)
15.6.2.2.1.4. Stereotactic Body Radiation Therapy
15.6.2.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
15.6.2.2.1.6. Others
15.6.2.2.2. Internal Beam Radiation Therapy
15.6.2.2.2.1. Brachytherapy Treatment
15.6.2.2.2.1.1. Low-dose rate (LDR) Brachytherapy
15.6.2.2.2.1.2. High-dose rate (HDR) Brachytherapy
15.6.2.2.2.2. Systemic Radiation Therapy
15.6.2.2.2.3. Radioimmunotherapy (RIT)
15.6.2.2.2.4. Others
15.6.2.3. UAE Radiation Therapy Market Revenue (US$ Mn)
and Forecasts, By Application
15.6.2.3.1. Breast Cancer
15.6.2.3.2. Eye Cancer
15.6.2.3.3. Prostate Cancer
15.6.2.3.4. Cervix Cancer
15.6.2.3.5. Lung Cancer
15.6.2.3.6. Head and Neck Cancer
15.6.2.3.7. Colorectal Cancer
15.6.2.3.8. Penile Cancer
15.6.2.3.9. Intracranial Cancer
15.6.2.3.10. Pancreatic Cancer
15.6.2.3.11. Vaginal Cancer
15.6.2.3.12. Others
15.6.2.4. UAE Radiation Therapy Market Revenue (US$ Mn)
and Forecasts, By End User
15.6.2.4.1. Hospitals
15.6.2.4.2. Clinics
15.6.2.4.3. Specialty Cancer Centers
15.6.2.4.4. Others
15.6.3. Egypt
15.6.3.1. Egypt Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
15.6.3.1.1. Products/Equipment
15.6.3.1.1.1. Imaging Systems
15.6.3.1.1.2. Linear Accelerator
15.6.3.1.1.3. Radio Therapy Simulators
15.6.3.1.1.4. Radioactive Seeds
15.6.3.1.1.5. Applicators and Afterloaders
15.6.3.1.1.6. Others
15.6.3.1.2. Services
15.6.3.1.2.1. Implementation and Installation
15.6.3.1.2.2. Training and Education
15.6.3.1.2.3. Support Services
15.6.3.1.2.4. Others
15.6.3.2. Egypt Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
15.6.3.2.1. External Beam Radiation Therapy
15.6.3.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
15.6.3.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
15.6.3.2.1.3. Image-Guided Radiation Therapy (IGRT)
15.6.3.2.1.4. Stereotactic Body Radiation Therapy
15.6.3.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
15.6.3.2.1.6. Others
15.6.3.2.2. Internal Beam Radiation Therapy
15.6.3.2.2.1. Brachytherapy Treatment
15.6.3.2.2.1.1. Low-dose rate (LDR) Brachytherapy
15.6.3.2.2.1.2. High-dose rate (HDR) Brachytherapy
15.6.3.2.2.2. Systemic Radiation Therapy
15.6.3.2.2.3. Radioimmunotherapy (RIT)
15.6.3.2.2.4. Others
15.6.3.3. Egypt Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
15.6.3.3.1. Breast Cancer
15.6.3.3.2. Eye Cancer
15.6.3.3.3. Prostate Cancer
15.6.3.3.4. Cervix Cancer
15.6.3.3.5. Lung Cancer
15.6.3.3.6. Head and Neck Cancer
15.6.3.3.7. Colorectal Cancer
15.6.3.3.8. Penile Cancer
15.6.3.3.9. Intracranial Cancer
15.6.3.3.10. Pancreatic Cancer
15.6.3.3.11. Vaginal Cancer
15.6.3.3.12. Others
15.6.3.4. Egypt Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
15.6.3.4.1. Hospitals
15.6.3.4.2. Clinics
15.6.3.4.3. Specialty Cancer Centers
15.6.3.4.4. Others
15.6.4. Kuwait
15.6.4.1. Kuwait Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
15.6.4.1.1. Products/Equipment
15.6.4.1.1.1. Imaging Systems
15.6.4.1.1.2. Linear Accelerator
15.6.4.1.1.3. Radio Therapy Simulators
15.6.4.1.1.4. Radioactive Seeds
15.6.4.1.1.5. Applicators and Afterloaders
15.6.4.1.1.6. Others
15.6.4.1.2. Services
15.6.4.1.2.1. Implementation and Installation
15.6.4.1.2.2. Training and Education
15.6.4.1.2.3. Support Services
15.6.4.1.2.4. Others
15.6.4.2. Kuwait Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
15.6.4.2.1. External Beam Radiation Therapy
15.6.4.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
15.6.4.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
15.6.4.2.1.3. Image-Guided Radiation Therapy (IGRT)
15.6.4.2.1.4. Stereotactic Body Radiation Therapy
15.6.4.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
15.6.4.2.1.6. Others
15.6.4.2.2. Internal Beam Radiation Therapy
15.6.4.2.2.1. Brachytherapy Treatment
15.6.4.2.2.1.1. Low-dose rate (LDR) Brachytherapy
15.6.4.2.2.1.2. High-dose rate (HDR) Brachytherapy
15.6.4.2.2.2. Systemic Radiation Therapy
15.6.4.2.2.3. Radioimmunotherapy (RIT)
15.6.4.2.2.4. Others
15.6.4.3. Kuwait Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
15.6.4.3.1. Breast Cancer
15.6.4.3.2. Eye Cancer
15.6.4.3.3. Prostate Cancer
15.6.4.3.4. Cervix Cancer
15.6.4.3.5. Lung Cancer
15.6.4.3.6. Head and Neck Cancer
15.6.4.3.7. Colorectal Cancer
15.6.4.3.8. Penile Cancer
15.6.4.3.9. Intracranial Cancer
15.6.4.3.10. Pancreatic Cancer
15.6.4.3.11. Vaginal Cancer
15.6.4.3.12. Others
15.6.4.4. Kuwait Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
15.6.4.4.1. Hospitals
15.6.4.4.2. Clinics
15.6.4.4.3. Specialty Cancer Centers
15.6.4.4.4. Others
15.6.5. South Africa
15.6.5.1. South Africa Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Offering
15.6.5.1.1. Products/Equipment
15.6.5.1.1.1. Imaging Systems
15.6.5.1.1.2. Linear Accelerator
15.6.5.1.1.3. Radio Therapy Simulators
15.6.5.1.1.4. Radioactive Seeds
15.6.5.1.1.5. Applicators and Afterloaders
15.6.5.1.1.6. Others
15.6.5.1.2. Services
15.6.5.1.2.1. Implementation and Installation
15.6.5.1.2.2. Training and Education
15.6.5.1.2.3. Support Services
15.6.5.1.2.4. Others
15.6.5.2. South Africa Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
15.6.5.2.1. External Beam Radiation Therapy
15.6.5.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
15.6.5.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
15.6.5.2.1.3. Image-Guided Radiation Therapy (IGRT)
15.6.5.2.1.4. Stereotactic Body Radiation Therapy
15.6.5.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
15.6.5.2.1.6. Others
15.6.5.2.2. Internal Beam Radiation Therapy
15.6.5.2.2.1. Brachytherapy Treatment
15.6.5.2.2.1.1. Low-dose rate (LDR) Brachytherapy
15.6.5.2.2.1.2. High-dose rate (HDR) Brachytherapy
15.6.5.2.2.2. Systemic Radiation Therapy
15.6.5.2.2.3. Radioimmunotherapy (RIT)
15.6.5.2.2.4. Others
15.6.5.3. South Africa Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Application
15.6.5.3.1. Breast Cancer
15.6.5.3.2. Eye Cancer
15.6.5.3.3. Prostate Cancer
15.6.5.3.4. Cervix Cancer
15.6.5.3.5. Lung Cancer
15.6.5.3.6. Head and Neck Cancer
15.6.5.3.7. Colorectal Cancer
15.6.5.3.8. Penile Cancer
15.6.5.3.9. Intracranial Cancer
15.6.5.3.10. Pancreatic Cancer
15.6.5.3.11. Vaginal Cancer
15.6.5.3.12. Others
15.6.5.4. South Africa Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By End User
15.6.5.4.1. Hospitals
15.6.5.4.2. Clinics
15.6.5.4.3. Specialty Cancer Centers
15.6.5.4.4. Others
15.6.6. Rest of Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Radiation
Therapy Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.6.1.1. Products/Equipment
15.6.6.1.1.1. Imaging Systems
15.6.6.1.1.2. Linear Accelerator
15.6.6.1.1.3. Radio Therapy Simulators
15.6.6.1.1.4. Radioactive Seeds
15.6.6.1.1.5. Applicators and Afterloaders
15.6.6.1.1.6. Others
15.6.6.1.2. Services
15.6.6.1.2.1. Implementation and Installation
15.6.6.1.2.2. Training and Education
15.6.6.1.2.3. Support Services
15.6.6.1.2.4. Others
15.6.6.2. Rest of Middle East & Africa Radiation
Therapy Market Revenue (US$ Mn) and Forecasts, By Therapy Type
15.6.6.2.1. External Beam Radiation Therapy
15.6.6.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
15.6.6.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
15.6.6.2.1.3. Image-Guided Radiation Therapy (IGRT)
15.6.6.2.1.4. Stereotactic Body Radiation Therapy
15.6.6.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
15.6.6.2.1.6. Others
15.6.6.2.2. Internal Beam Radiation Therapy
15.6.6.2.2.1. Brachytherapy Treatment
15.6.6.2.2.1.1. Low-dose rate (LDR) Brachytherapy
15.6.6.2.2.1.2. High-dose rate (HDR) Brachytherapy
15.6.6.2.2.2. Systemic Radiation Therapy
15.6.6.2.2.3. Radioimmunotherapy (RIT)
15.6.6.2.2.4. Others
15.6.6.3. Rest of Middle East & Africa Radiation
Therapy Market Revenue (US$ Mn) and Forecasts, By Application
15.6.6.3.1. Breast Cancer
15.6.6.3.2. Eye Cancer
15.6.6.3.3. Prostate Cancer
15.6.6.3.4. Cervix Cancer
15.6.6.3.5. Lung Cancer
15.6.6.3.6. Head and Neck Cancer
15.6.6.3.7. Colorectal Cancer
15.6.6.3.8. Penile Cancer
15.6.6.3.9. Intracranial Cancer
15.6.6.3.10. Pancreatic Cancer
15.6.6.3.11. Vaginal Cancer
15.6.6.3.12. Others
15.6.6.4. Rest of Middle East & Africa Radiation
Therapy Market Revenue (US$ Mn) and Forecasts, By End User
15.6.6.4.1. Hospitals
15.6.6.4.2. Clinics
15.6.6.4.3. Specialty Cancer Centers
15.6.6.4.4. Others
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Offering
15.7.3. By Therapy Type
15.7.4. By Application
15.7.5. By End User
16. Latin America Radiation Therapy Market
Analysis and Forecasts, 2019 - 2027
16.1. Overview
16.1.1. Latin America Radiation Therapy Market
Revenue (US$ Mn)
16.2. Latin America Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Offering
16.2.1. Products/Equipment
16.2.1.1. Imaging Systems
16.2.1.2. Linear Accelerator
16.2.1.3. Radio Therapy Simulators
16.2.1.4. Radioactive Seeds
16.2.1.5. Applicators and Afterloaders
16.2.1.6. Others
16.2.2. Services
16.2.2.1. Implementation and Installation
16.2.2.2. Training and Education
16.2.2.3. Support Services
16.2.2.4. Others
16.3. Latin America Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
16.3.1. External Beam Radiation Therapy
16.3.1.1. 3-D Conformal Radiation Therapy (3D CRT)
16.3.1.2. Intensity-Modulated Radiation Therapy (IMRT)
16.3.1.3. Image-Guided Radiation Therapy (IGRT)
16.3.1.4. Stereotactic Body Radiation Therapy
16.3.1.5. Volumetric Modulated Arc Therapy (VMAT)
16.3.1.6. Others
16.3.2. Internal Beam Radiation Therapy
16.3.2.1. Brachytherapy Treatment
16.3.2.1.1. Low-dose rate (LDR) Brachytherapy
16.3.2.1.2. High-dose rate (HDR) Brachytherapy
16.3.2.2. Systemic Radiation Therapy
16.3.2.3. Radioimmunotherapy (RIT)
16.3.2.4. Others
16.4. Latin America Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Application
16.4.1. Breast Cancer
16.4.2. Eye Cancer
16.4.3. Prostate Cancer
16.4.4. Cervix Cancer
16.4.5. Lung Cancer
16.4.6. Head and Neck Cancer
16.4.7. Colorectal Cancer
16.4.8. Penile Cancer
16.4.9. Intracranial Cancer
16.4.10. Pancreatic Cancer
16.4.11. Vaginal Cancer
16.4.12. Others
16.5. Latin America Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By End User
16.5.1. Hospitals
16.5.2. Clinics
16.5.3. Specialty Cancer Centers
16.5.4. Others
16.6. Latin America Radiation Therapy Market
Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Offering
16.6.1.1.1. Products/Equipment
16.6.1.1.1.1. Imaging Systems
16.6.1.1.1.2. Linear Accelerator
16.6.1.1.1.3. Radio Therapy Simulators
16.6.1.1.1.4. Radioactive Seeds
16.6.1.1.1.5. Applicators and Afterloaders
16.6.1.1.1.6. Others
16.6.1.1.2. Services
16.6.1.1.2.1. Implementation and Installation
16.6.1.1.2.2. Training and Education
16.6.1.1.2.3. Support Services
16.6.1.1.2.4. Others
16.6.1.2. Brazil Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
16.6.1.2.1. External Beam Radiation Therapy
16.6.1.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
16.6.1.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
16.6.1.2.1.3. Image-Guided Radiation Therapy (IGRT)
16.6.1.2.1.4. Stereotactic Body Radiation Therapy
16.6.1.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
16.6.1.2.1.6. Others
16.6.1.2.2. Internal Beam Radiation Therapy
16.6.1.2.2.1. Brachytherapy Treatment
16.6.1.2.2.1.1. Low-dose rate (LDR) Brachytherapy
16.6.1.2.2.1.2. High-dose rate (HDR) Brachytherapy
16.6.1.2.2.2. Systemic Radiation Therapy
16.6.1.2.2.3. Radioimmunotherapy (RIT)
16.6.1.2.2.4. Others
16.6.1.3. Brazil Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By Application
16.6.1.3.1. Breast Cancer
16.6.1.3.2. Eye Cancer
16.6.1.3.3. Prostate Cancer
16.6.1.3.4. Cervix Cancer
16.6.1.3.5. Lung Cancer
16.6.1.3.6. Head and Neck Cancer
16.6.1.3.7. Colorectal Cancer
16.6.1.3.8. Penile Cancer
16.6.1.3.9. Intracranial Cancer
16.6.1.3.10. Pancreatic Cancer
16.6.1.3.11. Vaginal Cancer
16.6.1.3.12. Others
16.6.1.4. Brazil Radiation Therapy Market Revenue (US$
Mn) and Forecasts, By End User
16.6.1.4.1. Hospitals
16.6.1.4.2. Clinics
16.6.1.4.3. Specialty Cancer Centers
16.6.1.4.4. Others
16.6.2. Argentina
16.6.2.1. Argentina Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Offering
16.6.2.1.1. Products/Equipment
16.6.2.1.1.1. Imaging Systems
16.6.2.1.1.2. Linear Accelerator
16.6.2.1.1.3. Radio Therapy Simulators
16.6.2.1.1.4. Radioactive Seeds
16.6.2.1.1.5. Applicators and Afterloaders
16.6.2.1.1.6. Others
16.6.2.1.2. Services
16.6.2.1.2.1. Implementation and Installation
16.6.2.1.2.2. Training and Education
16.6.2.1.2.3. Support Services
16.6.2.1.2.4. Others
16.6.2.2. Argentina Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
16.6.2.2.1. External Beam Radiation Therapy
16.6.2.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
16.6.2.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
16.6.2.2.1.3. Image-Guided Radiation Therapy (IGRT)
16.6.2.2.1.4. Stereotactic Body Radiation Therapy
16.6.2.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
16.6.2.2.1.6. Others
16.6.2.2.2. Internal Beam Radiation Therapy
16.6.2.2.2.1. Brachytherapy Treatment
16.6.2.2.2.1.1. Low-dose rate (LDR) Brachytherapy
16.6.2.2.2.1.2. High-dose rate (HDR) Brachytherapy
16.6.2.2.2.2. Systemic Radiation Therapy
16.6.2.2.2.3. Radioimmunotherapy (RIT)
16.6.2.2.2.4. Others
16.6.2.3. Argentina Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By Application
16.6.2.3.1. Breast Cancer
16.6.2.3.2. Eye Cancer
16.6.2.3.3. Prostate Cancer
16.6.2.3.4. Cervix Cancer
16.6.2.3.5. Lung Cancer
16.6.2.3.6. Head and Neck Cancer
16.6.2.3.7. Colorectal Cancer
16.6.2.3.8. Penile Cancer
16.6.2.3.9. Intracranial Cancer
16.6.2.3.10. Pancreatic Cancer
16.6.2.3.11. Vaginal Cancer
16.6.2.3.12. Others
16.6.2.4. Argentina Radiation Therapy Market Revenue
(US$ Mn) and Forecasts, By End User
16.6.2.4.1. Hospitals
16.6.2.4.2. Clinics
16.6.2.4.3. Specialty Cancer Centers
16.6.2.4.4. Others
16.6.3. Rest of Latin America
16.6.3.1. Rest of Latin America Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By Offering
16.6.3.1.1. Products/Equipment
16.6.3.1.1.1. Imaging Systems
16.6.3.1.1.2. Linear Accelerator
16.6.3.1.1.3. Radio Therapy Simulators
16.6.3.1.1.4. Radioactive Seeds
16.6.3.1.1.5. Applicators and Afterloaders
16.6.3.1.1.6. Others
16.6.3.1.2. Services
16.6.3.1.2.1. Implementation and Installation
16.6.3.1.2.2. Training and Education
16.6.3.1.2.3. Support Services
16.6.3.1.2.4. Others
16.6.3.2. Rest of Latin America Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
16.6.3.2.1. External Beam Radiation Therapy
16.6.3.2.1.1. 3-D Conformal Radiation Therapy (3D CRT)
16.6.3.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
16.6.3.2.1.3. Image-Guided Radiation Therapy (IGRT)
16.6.3.2.1.4. Stereotactic Body Radiation Therapy
16.6.3.2.1.5. Volumetric Modulated Arc Therapy (VMAT)
16.6.3.2.1.6. Others
16.6.3.2.2. Internal Beam Radiation Therapy
16.6.3.2.2.1. Brachytherapy Treatment
16.6.3.2.2.1.1. Low-dose rate (LDR) Brachytherapy
16.6.3.2.2.1.2. High-dose rate (HDR) Brachytherapy
16.6.3.2.2.2. Systemic Radiation Therapy
16.6.3.2.2.3. Radioimmunotherapy (RIT)
16.6.3.2.2.4. Others
16.6.3.3. Rest of Latin America Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By Application
16.6.3.3.1. Breast Cancer
16.6.3.3.2. Eye Cancer
16.6.3.3.3. Prostate Cancer
16.6.3.3.4. Cervix Cancer
16.6.3.3.5. Lung Cancer
16.6.3.3.6. Head and Neck Cancer
16.6.3.3.7. Colorectal Cancer
16.6.3.3.8. Penile Cancer
16.6.3.3.9. Intracranial Cancer
16.6.3.3.10. Pancreatic Cancer
16.6.3.3.11. Vaginal Cancer
16.6.3.3.12. Others
16.6.3.4. Rest of Latin America Radiation Therapy
Market Revenue (US$ Mn) and Forecasts, By End User
16.6.3.4.1. Hospitals
16.6.3.4.2. Clinics
16.6.3.4.3. Specialty Cancer Centers
16.6.3.4.4. Others
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Offering
16.7.3. By Therapy Type
16.7.4. By Application
16.7.5. By End User
17. Competitive Benchmarking
17.1. Market Share Analysis, 2018
17.2. Global Presence and Growth Strategies
17.2.1. Mergers and Acquisitions
17.2.2. Product Launches
17.2.3. Investments Trends
17.2.4. R&D Initiatives
18. Player Profiles
18.1. Accuray Incorporated
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Elekta AB
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Hitachi, Ltd
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. IBA Worldwide
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. IntraOp Medical, Inc
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Mevion Medical Systems
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. Nordion (Canada) Inc
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. Panacea Medical Technologies Pvt. Ltd
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. Provision Healthcare
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. Radiology Oncology Systems
18.10.1. Company Details
18.10.2. Company Overview
18.10.3. Product Offerings
18.10.4. Key Developments
18.10.5. Financial Analysis
18.10.6. SWOT Analysis
18.10.7. Business Strategies
18.11. Sensus Healthcare
18.11.1. Company Details
18.11.2. Company Overview
18.11.3. Product Offerings
18.11.4. Key Developments
18.11.5. Financial Analysis
18.11.6. SWOT Analysis
18.11.7. Business Strategies
18.12. Varian Medical Systems, Inc
18.12.1. Company Details
18.12.2. Company Overview
18.12.3. Product Offerings
18.12.4. Key Developments
18.12.5. Financial Analysis
18.12.6. SWOT Analysis
18.12.7. Business Strategies
18.13. VIEWRAY TECHNOLOGIES, INC
18.13.1. Company Details
18.13.2. Company Overview
18.13.3. Product Offerings
18.13.4. Key Developments
18.13.5. Financial Analysis
18.13.6. SWOT Analysis
18.13.7. Business Strategies
18.14. ZEISS Medical Technology
18.14.1. Company Details
18.14.2. Company Overview
18.14.3. Product Offerings
18.14.4. Key Developments
18.14.5. Financial Analysis
18.14.6. SWOT Analysis
18.14.7. Business Strategies
18.15. Other Industry Participants
19. Key
Findings
Note: This
ToC is tentative and can be changed according to the research study conducted
during the course of report completion.
**Exclusive for Multi-User and Enterprise User
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
